Irish Thoracic Society Podcast Productions https://irishthoracicsociety.com/ en Breath work A Respiratory Medicine podcast for busy respiratory nerds who want to keep up-to-date with the constantly evolving world of the lung. Every month we speak with respiratory experts on their areas of special interest. Our goal is to provide YOU with interactive and easy to listen to clinical updates. We will cover presentation, clinical reasoning, diagnostics and treatments but also new and exciting changes coming down the line. Delivered at a time convenient to you in 20-30 minute episodes. Inspire Meet your Respiratory Medicine heroes and hear how they got to where they are today. There are now more people than ever working in the respiratory medicine sphere. In this podcast we speak to Physicians, scientists, nurses, physiologists and more. We learn about their career paths to date, how they have achieved such success and advice for others hoping to follow suit. Some of these discussions are profession specific, but much of the advice is applicable to anyone trying to progress in their career. Social Media Website: https://irishthoracicsociety.com/ X/Twitter: irishthoracicS LinkedIn: Irish Thoracic Society  Instagram: Irishthoracicsociety https://megaphone.imgix.net/podcasts/b272cace-5b18-11ef-b7db-0bc9502ef8a9/image/46e673983b2be6e491fc2ddbe1c0618a.jpg?ixlib=rails-4.3.1&max-w=3000&max-h=3000&fit=crop&auto=format,compress Irish Thoracic Society Podcast Productions https://irishthoracicsociety.com/ no episodic Irish Thoracic Society Podcast Productions The Podcast Studios Breath work A Respiratory Medicine podcast for busy respiratory nerds who want to keep up-to-date with the constantly evolving world of the lung. Every month we speak with respiratory experts on their areas of special interest. Our goal is to provide YOU with interactive and easy to listen to clinical updates. We will cover presentation, clinical reasoning, diagnostics and treatments but also new and exciting changes coming down the line. Delivered at a time convenient to you in 20-30 minute episodes. Inspire Meet your Respiratory Medicine heroes and hear how they got to where they are today. There are now more people than ever working in the respiratory medicine sphere. In this podcast we speak to Physicians, scientists, nurses, physiologists and more. We learn about their career paths to date, how they have achieved such success and advice for others hoping to follow suit. Some of these discussions are profession specific, but much of the advice is applicable to anyone trying to progress in their career. Social Media Website: https://irishthoracicsociety.com/ X/Twitter: irishthoracicS LinkedIn: Irish Thoracic Society  Instagram: Irishthoracicsociety Breath work

A Respiratory Medicine podcast for busy respiratory nerds who want to keep up-to-date with the constantly evolving world of the lung. Every month we speak with respiratory experts on their areas of special interest.

Our goal is to provide YOU with interactive and easy to listen to clinical updates. We will cover presentation, clinical reasoning, diagnostics and treatments but also new and exciting changes coming down the line. Delivered at a time convenient to you in 20-30 minute episodes.


Inspire

Meet your Respiratory Medicine heroes and hear how they got to where they are today. There are now more people than ever working in the respiratory medicine sphere. In this podcast we speak to Physicians, scientists, nurses, physiologists and more. We learn about their career paths to date, how they have achieved such success and advice for others hoping to follow suit. Some of these discussions are profession specific, but much of the advice is applicable to anyone trying to progress in their career.


Social Media

Website: https://irishthoracicsociety.com/

X/Twitter: irishthoracicS

LinkedIn: Irish Thoracic Society 

Instagram: Irishthoracicsociety

]]> dan@headstuff.org Inspire: A Career in Cystic Fibrosis: From Registry Data to Transformative Therapies with Professor Edward McKone (Part 1) In this episode of Inspire, we are joined by Professor Edward McKone, Consultant Respiratory Physician at St. Vincent’s University Hospital and a leading figure in cystic fibrosis care. Drawing on his experience of clinical medicine, research, and leadership, he reflects on the evolution of CF management and the breakthroughs that have transformed patient outcomes. Alongside this, he shares insights from a dynamic career spanning clinical medicine, clinical trials, and the advancement of medical education. In this episode: Discover Professor McKone's path to specialising in respiratory medicine and cystic fibrosis. Explore the role of registries in improving patient outcomes and advancing standards. Learn about the challenges and successes in advocating for cystic fibrosis treatments. Understand the importance of medical education and the development of the Irish Clinical Educator Training program. Gain insights into the future of postgraduate medical training in Ireland. Hear Professor McKone's reflections on his career and advice for aspiring medical professionals. Guest: Professor Edward McKone is a leading respiratory physician and clinical professor based in Dublin, specialising in cystic fibrosis and respiratory disease. As a Consultant at St. Vincent’s University Hospital, he works at Ireland’s National Referral Centre for Adult Cystic Fibrosis, combining frontline care with clinical trials research. He has played a pivotal role in advancing cystic fibrosis treatment both in Ireland and internationally, including leadership roles with the Cystic Fibrosis Registry of Ireland and the European CF Registry. Alongside his clinical and research work, Professor McKone is deeply committed to medical education, currently serving as Dean of the Institute of Medicine and Co-Director of the Irish Clinician Educator Track. Hosts: Dr Barry Harnedy is a respiratory specialist trainee in Ireland. He graduated from National University of Ireland Galway. He is the current Irish Thoracic Society co Educational Officer. He is passionate about digital innovation and airways assessment. Sandra Green is an Irish-trained respiratory fellow with a strong track record in climate advocacy and multidisciplinary sustainable initiatives, as co-founder of Irish Doctors for the Environment. She has an MSc in Leadership and Innovation in Healthcare at the Royal College of Surgeons Ireland (2023–2025). With Marisssa, she co-founded the Irish Thoracic Society Podcast Productions, launching the platform in 2024 to share knowledge, insights, and innovations in respiratory care. LinkdIn linkedin.com/in/dr-sandra-green-2a9536199 Email - edofficer@irishthoracicsociety.com Chapters 00:00 – Intro & Guest Overview Overview of CF episode and Professor McKone’s background 02:15 – The Night That Changed a Career First on-call experience → choosing respiratory medicine 05:30 – Accidental Entry into Cystic FibrosisFrom “not knowing CF” to lifelong focus 09:00 – Medical Education & Leadership Pathways Role of National Specialty Director & training structures 11:30 – Rethinking Postgraduate Training in IrelandChallenges in BST → move toward broader exposure 17:00 – Building the Clinician-Educator (ICET Programme) Why medical education needs formal training pathways 23:00 – The Power of Registries From epidemiology → benchmarking → pharmacovigilance 27:30 – Registries as Regulatory Tools Landmark shift: EMA recognising CF registries for Phase IV studies 30:00 – How to Build a Registry (Practical Insights) Buy-in, minimal datasets, sustainability 32:15 – CFTR Modulators: Cost vs Value Clinical promise vs health economics reality 33:30 – The Sweat Chloride Moment (Key Turning Point) Why modulators changed everything 34:50 – Career Advice and reflections Career advice: focus, mentorship, and collaboration 36:30 – Closing Reflections References: O’Connor A. OPTIMISE: Optimisation and Progression of Training in Internal Medicine – In Search of Excellence (Interim Report). Dublin: Royal College of Physicians of Ireland; 2023. Corey M, McLaughlin FJ, Williams M, Levison H. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol. 1988;41(6):583-91. doi: 10.1016/0895-4356(88)90063-7. PMID: 3260274. Ramsey, B. W., et al. (1999). Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. New England Journal of Medicine. Mon, 20 Apr 2026 04:00:00 -0000 full The Podcast Studios In this episode of Inspire, we are joined by Professor Edward McKone, Consultant Respiratory Physician at St. Vincent’s University Hospital and a leading figure in cystic fibrosis care. Drawing on his experience of clinical medicine, research, and leadership, he reflects on the evolution of CF management and the breakthroughs that have transformed patient outcomes. Alongside this, he shares insights from a dynamic career spanning clinical medicine, clinical trials, and the advancement of medical education. In this episode: Discover Professor McKone's path to specialising in respiratory medicine and cystic fibrosis. Explore the role of registries in improving patient outcomes and advancing standards. Learn about the challenges and successes in advocating for cystic fibrosis treatments. Understand the importance of medical education and the development of the Irish Clinical Educator Training program. Gain insights into the future of postgraduate medical training in Ireland. Hear Professor McKone's reflections on his career and advice for aspiring medical professionals. Guest: Professor Edward McKone is a leading respiratory physician and clinical professor based in Dublin, specialising in cystic fibrosis and respiratory disease. As a Consultant at St. Vincent’s University Hospital, he works at Ireland’s National Referral Centre for Adult Cystic Fibrosis, combining frontline care with clinical trials research. He has played a pivotal role in advancing cystic fibrosis treatment both in Ireland and internationally, including leadership roles with the Cystic Fibrosis Registry of Ireland and the European CF Registry. Alongside his clinical and research work, Professor McKone is deeply committed to medical education, currently serving as Dean of the Institute of Medicine and Co-Director of the Irish Clinician Educator Track. Hosts: Dr Barry Harnedy is a respiratory specialist trainee in Ireland. He graduated from National University of Ireland Galway. He is the current Irish Thoracic Society co Educational Officer. He is passionate about digital innovation and airways assessment. Sandra Green is an Irish-trained respiratory fellow with a strong track record in climate advocacy and multidisciplinary sustainable initiatives, as co-founder of Irish Doctors for the Environment. She has an MSc in Leadership and Innovation in Healthcare at the Royal College of Surgeons Ireland (2023–2025). With Marisssa, she co-founded the Irish Thoracic Society Podcast Productions, launching the platform in 2024 to share knowledge, insights, and innovations in respiratory care. LinkdIn linkedin.com/in/dr-sandra-green-2a9536199 Email - edofficer@irishthoracicsociety.com Chapters 00:00 – Intro & Guest Overview Overview of CF episode and Professor McKone’s background 02:15 – The Night That Changed a Career First on-call experience → choosing respiratory medicine 05:30 – Accidental Entry into Cystic FibrosisFrom “not knowing CF” to lifelong focus 09:00 – Medical Education & Leadership Pathways Role of National Specialty Director & training structures 11:30 – Rethinking Postgraduate Training in IrelandChallenges in BST → move toward broader exposure 17:00 – Building the Clinician-Educator (ICET Programme) Why medical education needs formal training pathways 23:00 – The Power of Registries From epidemiology → benchmarking → pharmacovigilance 27:30 – Registries as Regulatory Tools Landmark shift: EMA recognising CF registries for Phase IV studies 30:00 – How to Build a Registry (Practical Insights) Buy-in, minimal datasets, sustainability 32:15 – CFTR Modulators: Cost vs Value Clinical promise vs health economics reality 33:30 – The Sweat Chloride Moment (Key Turning Point) Why modulators changed everything 34:50 – Career Advice and reflections Career advice: focus, mentorship, and collaboration 36:30 – Closing Reflections References: O’Connor A. OPTIMISE: Optimisation and Progression of Training in Internal Medicine – In Search of Excellence (Interim Report). Dublin: Royal College of Physicians of Ireland; 2023. Corey M, McLaughlin FJ, Williams M, Levison H. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol. 1988;41(6):583-91. doi: 10.1016/0895-4356(88)90063-7. PMID: 3260274. Ramsey, B. W., et al. (1999). Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. New England Journal of Medicine. In this episode of Inspire, we are joined by Professor Edward McKone, Consultant Respiratory Physician at St. Vincent’s University Hospital and a leading figure in cystic fibrosis care. Drawing on his experience of clinical medicine, research, and leadership, he reflects on the evolution of CF management and the breakthroughs that have transformed patient outcomes. Alongside this, he shares insights from a dynamic career spanning clinical medicine, clinical trials, and the advancement of medical education.


In this episode:

Discover Professor McKone's path to specialising in respiratory medicine and cystic fibrosis.

Explore the role of registries in improving patient outcomes and advancing standards.

Learn about the challenges and successes in advocating for cystic fibrosis treatments.

Understand the importance of medical education and the development of the Irish Clinical Educator Training program.

Gain insights into the future of postgraduate medical training in Ireland.

Hear Professor McKone's reflections on his career and advice for aspiring medical professionals.


Guest:

Professor Edward McKone is a leading respiratory physician and clinical professor based in Dublin, specialising in cystic fibrosis and respiratory disease. As a Consultant at St. Vincent’s University Hospital, he works at Ireland’s National Referral Centre for Adult Cystic Fibrosis, combining frontline care with clinical trials research.

He has played a pivotal role in advancing cystic fibrosis treatment both in Ireland and internationally, including leadership roles with the Cystic Fibrosis Registry of Ireland and the European CF Registry. Alongside his clinical and research work, Professor McKone is deeply committed to medical education, currently serving as Dean of the Institute of Medicine and Co-Director of the Irish Clinician Educator Track.


Hosts:

Dr Barry Harnedy is a respiratory specialist trainee in Ireland. He graduated from National University of Ireland Galway. He is the current Irish Thoracic Society co Educational Officer. He is passionate about digital innovation and airways assessment.


Sandra Green is an Irish-trained respiratory fellow with a strong track record in climate advocacy and multidisciplinary sustainable initiatives, as co-founder of Irish Doctors for the Environment. She has an MSc in Leadership and Innovation in Healthcare at the Royal College of Surgeons Ireland (2023–2025). With Marisssa, she co-founded the Irish Thoracic Society Podcast Productions, launching the platform in 2024 to share knowledge, insights, and innovations in respiratory care.

LinkdIn linkedin.com/in/dr-sandra-green-2a9536199

Email - edofficer@irishthoracicsociety.com


Chapters

00:00 – Intro & Guest Overview Overview of CF episode and Professor McKone’s background

02:15 – The Night That Changed a Career First on-call experience → choosing respiratory medicine

05:30 – Accidental Entry into Cystic FibrosisFrom “not knowing CF” to lifelong focus

09:00 – Medical Education & Leadership Pathways Role of National Specialty Director & training structures

11:30 – Rethinking Postgraduate Training in IrelandChallenges in BST → move toward broader exposure

17:00 – Building the Clinician-Educator (ICET Programme) Why medical education needs formal training pathways

23:00 – The Power of Registries From epidemiology → benchmarking → pharmacovigilance

27:30 – Registries as Regulatory Tools Landmark shift: EMA recognising CF registries for Phase IV studies

30:00 – How to Build a Registry (Practical Insights) Buy-in, minimal datasets, sustainability

32:15 – CFTR Modulators: Cost vs Value Clinical promise vs health economics reality

33:30 – The Sweat Chloride Moment (Key Turning Point) Why modulators changed everything

34:50 – Career Advice and reflections Career advice: focus, mentorship, and collaboration

36:30 – Closing Reflections


References:

O’Connor A. OPTIMISE: Optimisation and Progression of Training in Internal Medicine – In Search of Excellence (Interim Report). Dublin: Royal College of Physicians of Ireland; 2023.

Corey M, McLaughlin FJ, Williams M, Levison H. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol. 1988;41(6):583-91. doi: 10.1016/0895-4356(88)90063-7. PMID: 3260274.

Ramsey, B. W., et al. (1999). Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. New England Journal of Medicine.

]]> 2146 PulmPeeps / Irish Thoracic Society collaboration: Understanding Refractory Chronic Cough: Insights from Experts In this episode, we explore the complex and often overlooked world of refractory chronic cough—a condition that can significantly impact patients’ quality of life, yet is frequently misunderstood or underdiagnosed. Featuring insights from leading respiratory specialists in Ireland and the United States, we examine the latest approaches to diagnosis, management, and emerging treatments aimed at improving patient outcomes and supporting clinicians in navigating this challenging area of respiratory medicine. Our guests, Professor Lorcan McGarvey and Professor Brendan Canning—both internationally recognised leaders in respiratory medicine and cough research—share their expertise on the neurobiology of chronic cough, the substantial morbidity experienced by patients, and strategies for more effective diagnostic investigation. We also discuss current treatment options and promising therapies on the horizon, as chronic cough increasingly gains recognition as a disease in its own right rather than merely a symptom. Whether you are a clinician, researcher, or simply interested in advances in respiratory medicine, this episode offers valuable insights into a condition that is finally receiving the attention it deserves. -- Guests Professor Lorcan McGarvey Professor of Respiratory Medicine at the University of Belfast, with a focus on the neurobiology of cough. His research has significantly advanced understanding of cough hypersensitivity syndrome and contributed to the development of new therapeutic strategies. He is widely respected for his collaborative work and dedication to improving respiratory health. Professor Brendan Canning Distinguished researcher at Johns Hopkins University, specialising in the mechanisms of cough and airway diseases. His pioneering studies on neural pathways and receptor targets have helped pave the way for novel treatments in refractory chronic cough. He is recognised as a key figure in efforts to redefine chronic cough management. Hosts Dr Marissa O’Callaghan Irish-trained respiratory fellow currently undertaking a postdoctoral fellowship at Erasmus MC Rotterdam in the Netherlands. She completed her training in Respiratory and Internal Medicine, along with her PhD, in 2025. Her interests include interstitial and rare lung diseases, as well as clinical research, medical education, and innovation. She co-founded the ITS Podcast Series in June 2024 alongside Sandra Green. Dr Sandra Green Irish-trained respiratory fellow with a strong background in climate advocacy and multidisciplinary sustainability initiatives. She is co-founder of Irish Doctors for the Environment and completed an MSc in Leadership and Innovation in Healthcare at the Royal College of Surgeons in Ireland (2023–2025). Alongside Marissa O’Callaghan, she co-founded Irish Thoracic Society Podcast Productions in 2024 to share knowledge and innovation in respiratory care. Tue, 07 Apr 2026 13:22:00 -0000 full The Podcast Studios In this episode, we explore the complex and often overlooked world of refractory chronic cough—a condition that can significantly impact patients’ quality of life, yet is frequently misunderstood or underdiagnosed. Featuring insights from leading respiratory specialists in Ireland and the United States, we examine the latest approaches to diagnosis, management, and emerging treatments aimed at improving patient outcomes and supporting clinicians in navigating this challenging area of respiratory medicine. Our guests, Professor Lorcan McGarvey and Professor Brendan Canning—both internationally recognised leaders in respiratory medicine and cough research—share their expertise on the neurobiology of chronic cough, the substantial morbidity experienced by patients, and strategies for more effective diagnostic investigation. We also discuss current treatment options and promising therapies on the horizon, as chronic cough increasingly gains recognition as a disease in its own right rather than merely a symptom. Whether you are a clinician, researcher, or simply interested in advances in respiratory medicine, this episode offers valuable insights into a condition that is finally receiving the attention it deserves. -- Guests Professor Lorcan McGarvey Professor of Respiratory Medicine at the University of Belfast, with a focus on the neurobiology of cough. His research has significantly advanced understanding of cough hypersensitivity syndrome and contributed to the development of new therapeutic strategies. He is widely respected for his collaborative work and dedication to improving respiratory health. Professor Brendan Canning Distinguished researcher at Johns Hopkins University, specialising in the mechanisms of cough and airway diseases. His pioneering studies on neural pathways and receptor targets have helped pave the way for novel treatments in refractory chronic cough. He is recognised as a key figure in efforts to redefine chronic cough management. Hosts Dr Marissa O’Callaghan Irish-trained respiratory fellow currently undertaking a postdoctoral fellowship at Erasmus MC Rotterdam in the Netherlands. She completed her training in Respiratory and Internal Medicine, along with her PhD, in 2025. Her interests include interstitial and rare lung diseases, as well as clinical research, medical education, and innovation. She co-founded the ITS Podcast Series in June 2024 alongside Sandra Green. Dr Sandra Green Irish-trained respiratory fellow with a strong background in climate advocacy and multidisciplinary sustainability initiatives. She is co-founder of Irish Doctors for the Environment and completed an MSc in Leadership and Innovation in Healthcare at the Royal College of Surgeons in Ireland (2023–2025). Alongside Marissa O’Callaghan, she co-founded Irish Thoracic Society Podcast Productions in 2024 to share knowledge and innovation in respiratory care. In this episode, we explore the complex and often overlooked world of refractory chronic cough—a condition that can significantly impact patients’ quality of life, yet is frequently misunderstood or underdiagnosed. Featuring insights from leading respiratory specialists in Ireland and the United States, we examine the latest approaches to diagnosis, management, and emerging treatments aimed at improving patient outcomes and supporting clinicians in navigating this challenging area of respiratory medicine.

Our guests, Professor Lorcan McGarvey and Professor Brendan Canning—both internationally recognised leaders in respiratory medicine and cough research—share their expertise on the neurobiology of chronic cough, the substantial morbidity experienced by patients, and strategies for more effective diagnostic investigation. We also discuss current treatment options and promising therapies on the horizon, as chronic cough increasingly gains recognition as a disease in its own right rather than merely a symptom. Whether you are a clinician, researcher, or simply interested in advances in respiratory medicine, this episode offers valuable insights into a condition that is finally receiving the attention it deserves.

-- Guests

Professor Lorcan McGarvey Professor of Respiratory Medicine at the University of Belfast, with a focus on the neurobiology of cough. His research has significantly advanced understanding of cough hypersensitivity syndrome and contributed to the development of new therapeutic strategies. He is widely respected for his collaborative work and dedication to improving respiratory health.

Professor Brendan Canning Distinguished researcher at Johns Hopkins University, specialising in the mechanisms of cough and airway diseases. His pioneering studies on neural pathways and receptor targets have helped pave the way for novel treatments in refractory chronic cough. He is recognised as a key figure in efforts to redefine chronic cough management.

Hosts Dr Marissa O’Callaghan Irish-trained respiratory fellow currently undertaking a postdoctoral fellowship at Erasmus MC Rotterdam in the Netherlands. She completed her training in Respiratory and Internal Medicine, along with her PhD, in 2025. Her interests include interstitial and rare lung diseases, as well as clinical research, medical education, and innovation. She co-founded the ITS Podcast Series in June 2024 alongside Sandra Green.


Dr Sandra Green Irish-trained respiratory fellow with a strong background in climate advocacy and multidisciplinary sustainability initiatives. She is co-founder of Irish Doctors for the Environment and completed an MSc in Leadership and Innovation in Healthcare at the Royal College of Surgeons in Ireland (2023–2025). Alongside Marissa O’Callaghan, she co-founded Irish Thoracic Society Podcast Productions in 2024 to share knowledge and innovation in respiratory care.

]]> 3371 Breathwork: Alpha-1 Antitrypsin Deficiency: Insights from Professor Gerry McElvaney (Part 2) This episode explores Alpha-1 Antitrypsin Deficiency, focusing on diagnosis, pathophysiology, and evolving treatments. Professor Gerry McElvaney discusses prevalence in Ireland, the impact on lung and liver disease, and why early detection significantly improves outcomes. Key topics include: Prevalence and genotypes (ZZ, MZ, SZ) Lung and liver disease, plus manifestations like panniculitis and vasculitis Diagnostic challenges: levels vs genotype/phenotype and need for multimodal testing Importance of early detection, smoking cessation, and targeted intervention Emerging therapies: RNA editing, gene silencing, and potential cures Screening strategies, including newborn screening and cost-benefit considerations Role of polymers in disease progression Gaps in treatment access and need for healthcare reform Professor Gerry McElvaney is a global leader in Alpha-1 research, founder of the Alpha-1 Foundation of Ireland, and Director of the Cystic Fibrosis Unit at Beaumont Hospital. His work has positioned Ireland at the forefront of Alpha-1 detection and research. Hosts: Dr Barry Harnedy – Respiratory trainee, Irish Thoracic Society Educational Officer Sandra Green – Respiratory fellow, co-founder of Irish Doctors for the Environment and ITS Podcast Productions Contact: edofficer@irishthoracicsociety.com Chapters (highlights): 00:05 Intro | 01:00 Vaping & inflammation | 02:00 Diagnosis pitfalls 03:20 Future therapies | 04:50 Screening importance | 07:00 Treatment advances 10:00 Genetics explained | 12:00 Smoking impact | 13:40 Newborn screening 16:00 Gene therapies | 17:30 Key takeaways Key message: Test comprehensively, detect early, intervene early, and remain optimistic about emerging therapies. References: Fraughen DD, et al. Am J Respir Crit Care Med. 2023;208:964–974. McElvaney NG, et al. Lancet Respir Med. 2017;5:51–60. Molloy K, et al. Am J Respir Crit Care Med. 2014;189:419–427. Franciosi AN, et al. Am J Respir Crit Care Med. 2020;202:73–82. Leacy EJ, et al. Am J Respir Crit Care Med. 2025;211:2408–2410. McElvaney OJ, et al. Med (N Y). 2022;3:233–248. Franciosi AN, et al. COPD. 2021;18:76–82. Fri, 03 Apr 2026 10:10:00 -0000 full The Podcast Studios This episode explores Alpha-1 Antitrypsin Deficiency, focusing on diagnosis, pathophysiology, and evolving treatments. Professor Gerry McElvaney discusses prevalence in Ireland, the impact on lung and liver disease, and why early detection significantly improves outcomes. Key topics include: Prevalence and genotypes (ZZ, MZ, SZ) Lung and liver disease, plus manifestations like panniculitis and vasculitis Diagnostic challenges: levels vs genotype/phenotype and need for multimodal testing Importance of early detection, smoking cessation, and targeted intervention Emerging therapies: RNA editing, gene silencing, and potential cures Screening strategies, including newborn screening and cost-benefit considerations Role of polymers in disease progression Gaps in treatment access and need for healthcare reform Professor Gerry McElvaney is a global leader in Alpha-1 research, founder of the Alpha-1 Foundation of Ireland, and Director of the Cystic Fibrosis Unit at Beaumont Hospital. His work has positioned Ireland at the forefront of Alpha-1 detection and research. Hosts: Dr Barry Harnedy – Respiratory trainee, Irish Thoracic Society Educational Officer Sandra Green – Respiratory fellow, co-founder of Irish Doctors for the Environment and ITS Podcast Productions Contact: edofficer@irishthoracicsociety.com Chapters (highlights): 00:05 Intro | 01:00 Vaping & inflammation | 02:00 Diagnosis pitfalls 03:20 Future therapies | 04:50 Screening importance | 07:00 Treatment advances 10:00 Genetics explained | 12:00 Smoking impact | 13:40 Newborn screening 16:00 Gene therapies | 17:30 Key takeaways Key message: Test comprehensively, detect early, intervene early, and remain optimistic about emerging therapies. References: Fraughen DD, et al. Am J Respir Crit Care Med. 2023;208:964–974. McElvaney NG, et al. Lancet Respir Med. 2017;5:51–60. Molloy K, et al. Am J Respir Crit Care Med. 2014;189:419–427. Franciosi AN, et al. Am J Respir Crit Care Med. 2020;202:73–82. Leacy EJ, et al. Am J Respir Crit Care Med. 2025;211:2408–2410. McElvaney OJ, et al. Med (N Y). 2022;3:233–248. Franciosi AN, et al. COPD. 2021;18:76–82. This episode explores Alpha-1 Antitrypsin Deficiency, focusing on diagnosis, pathophysiology, and evolving treatments. Professor Gerry McElvaney discusses prevalence in Ireland, the impact on lung and liver disease, and why early detection significantly improves outcomes.


Key topics include:


Prevalence and genotypes (ZZ, MZ, SZ)

Lung and liver disease, plus manifestations like panniculitis and vasculitis

Diagnostic challenges: levels vs genotype/phenotype and need for multimodal testing

Importance of early detection, smoking cessation, and targeted intervention

Emerging therapies: RNA editing, gene silencing, and potential cures

Screening strategies, including newborn screening and cost-benefit considerations

Role of polymers in disease progression

Gaps in treatment access and need for healthcare reform


Professor Gerry McElvaney is a global leader in Alpha-1 research, founder of the Alpha-1 Foundation of Ireland, and Director of the Cystic Fibrosis Unit at Beaumont Hospital. His work has positioned Ireland at the forefront of Alpha-1 detection and research.


Hosts:

Dr Barry Harnedy – Respiratory trainee, Irish Thoracic Society Educational Officer

Sandra Green – Respiratory fellow, co-founder of Irish Doctors for the Environment and ITS Podcast Productions


Contact: edofficer@irishthoracicsociety.com


Chapters (highlights):

00:05 Intro | 01:00 Vaping & inflammation | 02:00 Diagnosis pitfalls

03:20 Future therapies | 04:50 Screening importance | 07:00 Treatment advances

10:00 Genetics explained | 12:00 Smoking impact | 13:40 Newborn screening

16:00 Gene therapies | 17:30 Key takeaways


Key message: Test comprehensively, detect early, intervene early, and remain optimistic about emerging therapies.


References:

Fraughen DD, et al. Am J Respir Crit Care Med. 2023;208:964–974.

McElvaney NG, et al. Lancet Respir Med. 2017;5:51–60.

Molloy K, et al. Am J Respir Crit Care Med. 2014;189:419–427.

Franciosi AN, et al. Am J Respir Crit Care Med. 2020;202:73–82.

Leacy EJ, et al. Am J Respir Crit Care Med. 2025;211:2408–2410.

McElvaney OJ, et al. Med (N Y). 2022;3:233–248.

Franciosi AN, et al. COPD. 2021;18:76–82.

]]> 2079 Inspire: From Bench to Bedside: The Journey of Professor Gerry McElvaney in Alpha-1 Research (Part 1) In this episode, we explore the remarkable career of Professor Gerry McElvaney, a world-leading figure in Alpha-1 antitrypsin deficiency research and translational medicine. Gerry shares his journey from clinical medicine to pioneering discovery science, revealing how curiosity, perseverance, and strategic thinking can drive real-world clinical breakthroughs. From building a research laboratory from scratch to establishing Ireland’s first national targeted detection programmes, Gerry reflects on the challenges of advocacy, diagnostics, and innovation. He discusses pioneering therapeutic development, lessons from high-profile research failures, and how unexpected influences—such as Dolly the sheep—shaped scientific understanding of protein therapies and treatment design. The conversation spans early detection, personalised medicine, gene editing, and the future of genetic lung disease, while also highlighting the human side of science: mentorship, multidisciplinary teamwork, patient-centred foundations, and the power of listening to clinical questions as the spark for transformative research. This episode is a masterclass in translational medicine—connecting bedside observations to laboratory discovery and back again—offering invaluable insight for clinicians, researchers, and early-career innovators. • Transition from clinical medicine to translational research • Establishing Ireland’s first Alpha-1 diagnostic and detection programmes • Advocacy with hospitals and government agencies • Lessons from gene therapy and research setbacks • Dolly the sheep and protein half-life discoveries • Funding strategies and research sustainability • Multidisciplinary team building • Patient foundations and community engagement • Future visions: early detection, AI, and gene editing • Translating ward-round questions into research breakthroughs Professor Gerry McElvaney is a world-renowned expert in Alpha-1 antitrypsin deficiency. He founded the Alpha-1 Foundation of Ireland and established Europe’s first national targeted detection programme. He is Director of the Cystic Fibrosis Unit at Beaumont Hospital, where his work spans cystic fibrosis, Alpha-1 antitrypsin deficiency, infection, and immunity. His leadership has transformed Ireland into a global hub for Alpha-1 research and patient care. Dr Barry Harnedy – Respiratory specialist trainee, digital innovation advocate, and current co-Educational Officer of the Irish Thoracic Society. Sandra Green – Irish-trained respiratory fellow, climate advocate, co-founder of Irish Doctors for the Environment, MSc in Leadership & Innovation in Healthcare at Royal College of Surgeons Ireland, and co-founder of Irish Thoracic Society Podcast Productions. 00:00 Welcome & introduction 05:46 National detection & screening journey 09:34 Dolly the sheep & protein research 12:30 Translational research in action 17:21 Gender differences in CF outcomes 27:05 Alpha-1 Foundation & community impact 30:30 Future visions: AI & gene editing 33:23 Advice for early-career clinicians Mon, 02 Mar 2026 05:00:00 -0000 full The Podcast Studios In this episode, we explore the remarkable career of Professor Gerry McElvaney, a world-leading figure in Alpha-1 antitrypsin deficiency research and translational medicine. Gerry shares his journey from clinical medicine to pioneering discovery science, revealing how curiosity, perseverance, and strategic thinking can drive real-world clinical breakthroughs. From building a research laboratory from scratch to establishing Ireland’s first national targeted detection programmes, Gerry reflects on the challenges of advocacy, diagnostics, and innovation. He discusses pioneering therapeutic development, lessons from high-profile research failures, and how unexpected influences—such as Dolly the sheep—shaped scientific understanding of protein therapies and treatment design. The conversation spans early detection, personalised medicine, gene editing, and the future of genetic lung disease, while also highlighting the human side of science: mentorship, multidisciplinary teamwork, patient-centred foundations, and the power of listening to clinical questions as the spark for transformative research. This episode is a masterclass in translational medicine—connecting bedside observations to laboratory discovery and back again—offering invaluable insight for clinicians, researchers, and early-career innovators. • Transition from clinical medicine to translational research • Establishing Ireland’s first Alpha-1 diagnostic and detection programmes • Advocacy with hospitals and government agencies • Lessons from gene therapy and research setbacks • Dolly the sheep and protein half-life discoveries • Funding strategies and research sustainability • Multidisciplinary team building • Patient foundations and community engagement • Future visions: early detection, AI, and gene editing • Translating ward-round questions into research breakthroughs Professor Gerry McElvaney is a world-renowned expert in Alpha-1 antitrypsin deficiency. He founded the Alpha-1 Foundation of Ireland and established Europe’s first national targeted detection programme. He is Director of the Cystic Fibrosis Unit at Beaumont Hospital, where his work spans cystic fibrosis, Alpha-1 antitrypsin deficiency, infection, and immunity. His leadership has transformed Ireland into a global hub for Alpha-1 research and patient care. Dr Barry Harnedy – Respiratory specialist trainee, digital innovation advocate, and current co-Educational Officer of the Irish Thoracic Society. Sandra Green – Irish-trained respiratory fellow, climate advocate, co-founder of Irish Doctors for the Environment, MSc in Leadership & Innovation in Healthcare at Royal College of Surgeons Ireland, and co-founder of Irish Thoracic Society Podcast Productions. 00:00 Welcome & introduction 05:46 National detection & screening journey 09:34 Dolly the sheep & protein research 12:30 Translational research in action 17:21 Gender differences in CF outcomes 27:05 Alpha-1 Foundation & community impact 30:30 Future visions: AI & gene editing 33:23 Advice for early-career clinicians In this episode, we explore the remarkable career of Professor Gerry McElvaney, a world-leading figure in Alpha-1 antitrypsin deficiency research and translational medicine. Gerry shares his journey from clinical medicine to pioneering discovery science, revealing how curiosity, perseverance, and strategic thinking can drive real-world clinical breakthroughs.

From building a research laboratory from scratch to establishing Ireland’s first national targeted detection programmes, Gerry reflects on the challenges of advocacy, diagnostics, and innovation. He discusses pioneering therapeutic development, lessons from high-profile research failures, and how unexpected influences—such as Dolly the sheep—shaped scientific understanding of protein therapies and treatment design.

The conversation spans early detection, personalised medicine, gene editing, and the future of genetic lung disease, while also highlighting the human side of science: mentorship, multidisciplinary teamwork, patient-centred foundations, and the power of listening to clinical questions as the spark for transformative research.

This episode is a masterclass in translational medicine—connecting bedside observations to laboratory discovery and back again—offering invaluable insight for clinicians, researchers, and early-career innovators.

• Transition from clinical medicine to translational research • Establishing Ireland’s first Alpha-1 diagnostic and detection programmes • Advocacy with hospitals and government agencies • Lessons from gene therapy and research setbacks • Dolly the sheep and protein half-life discoveries • Funding strategies and research sustainability • Multidisciplinary team building • Patient foundations and community engagement • Future visions: early detection, AI, and gene editing • Translating ward-round questions into research breakthroughs


Professor Gerry McElvaney is a world-renowned expert in Alpha-1 antitrypsin deficiency. He founded the Alpha-1 Foundation of Ireland and established Europe’s first national targeted detection programme. He is Director of the Cystic Fibrosis Unit at Beaumont Hospital, where his work spans cystic fibrosis, Alpha-1 antitrypsin deficiency, infection, and immunity. His leadership has transformed Ireland into a global hub for Alpha-1 research and patient care.

Dr Barry Harnedy – Respiratory specialist trainee, digital innovation advocate, and current co-Educational Officer of the Irish Thoracic Society.

Sandra Green – Irish-trained respiratory fellow, climate advocate, co-founder of Irish Doctors for the Environment, MSc in Leadership & Innovation in Healthcare at Royal College of Surgeons Ireland, and co-founder of Irish Thoracic Society Podcast Productions.


00:00 Welcome & introduction 05:46 National detection & screening journey 09:34 Dolly the sheep & protein research 12:30 Translational research in action 17:21 Gender differences in CF outcomes 27:05 Alpha-1 Foundation & community impact 30:30 Future visions: AI & gene editing 33:23 Advice for early-career clinicians

]]> 2156 Inspire (Part 2) – Professional Branding in Healthcare Careers with Sarah Geraghty In this episode, Sarah Geraghty shares clear, practical strategies for healthcare professionals who want to advance their careers with intention. From defining your personal brand to building meaningful networks, this conversation focuses on reflection, self-awareness, and strategic action as the foundations of sustainable growth in a demanding field. In this episode, we explore: -The most common mistake in healthcare career planning: an unclear personal brand. -How to define and communicate your professional brand effectively - The importance of self-awareness and aligning your actions with your brand - Practical steps to assess and close gaps between how you're perceived and how you want to be seen - Balancing technical expertise with communication skills for career progression - Customising your brand for different stakeholders and career stages - Building meaningful, high-quality relationships over superficial connections - The role of reflection and goal-setting in strategic career planning - Staying authentic while adapting your persona to different professional contexts Guest Sarah Geraghty is Head of Careers at The Communications Clinics, specialising in high-stakes interview preparation and career transitions. A seasoned communication trainer and coach, she blends practical storytelling with leadership development to help professionals articulate their value clearly and confidently. With a background in journalism and editorial work, including contributions to The Irish Times and The Journal, and experience as Assistant Editor of Gloss Magazine, Sarah brings real-world insight into performing under pressure in healthcare and beyond. Hosts Marissa O’Callaghan is an Irish-trained Respiratory Fellow currently undertaking a post-doc fellowship at Erasmus MC Rotterdam in the Netherlands. She completed Irish respiratory and internal medicine training and her PhD in 2025. Her interests include interstitial and rare lung diseases, clinical research, medical education, and medical innovation. Together with co-host Sandra Green, she founded the ITS podcast series in June 2024. Sandra Green is an Irish-trained respiratory doctor and climate advocate, and co-founder of Irish Doctors for the Environment. She holds an MSc in Leadership and Innovation in Healthcare from the Royal College of Surgeons Ireland (2023–2025). With Marissa, she co-founded the Irish Thoracic Society Podcast Productions in 2024 to share knowledge, insights, and innovation in respiratory care. Chapters: 00:00 – Navigating Career Development in Healthcare 01:56 – Understanding Professional Branding 09:37 – The Importance of Communication Skills 11:52 – Practical Steps for Building and Demonstrating Your Brand 14:19 – Communicating Technical Skills and Intentional Self-Promotion 18:23 – Staying Authentic While Adapting Your Brand 21:42 – Actionable Steps for Career Advancement Resources & Links - Sarah Geraghty – LinkedIn: https://ie.linkedin.com/in/sarah-geraghty-comms - The Communication Clinic: https://www.communicationsclinic.ie/ Mon, 16 Feb 2026 11:38:00 -0000 full The Podcast Studios In this episode, Sarah Geraghty shares clear, practical strategies for healthcare professionals who want to advance their careers with intention. From defining your personal brand to building meaningful networks, this conversation focuses on reflection, self-awareness, and strategic action as the foundations of sustainable growth in a demanding field. In this episode, we explore: -The most common mistake in healthcare career planning: an unclear personal brand. -How to define and communicate your professional brand effectively - The importance of self-awareness and aligning your actions with your brand - Practical steps to assess and close gaps between how you're perceived and how you want to be seen - Balancing technical expertise with communication skills for career progression - Customising your brand for different stakeholders and career stages - Building meaningful, high-quality relationships over superficial connections - The role of reflection and goal-setting in strategic career planning - Staying authentic while adapting your persona to different professional contexts Guest Sarah Geraghty is Head of Careers at The Communications Clinics, specialising in high-stakes interview preparation and career transitions. A seasoned communication trainer and coach, she blends practical storytelling with leadership development to help professionals articulate their value clearly and confidently. With a background in journalism and editorial work, including contributions to The Irish Times and The Journal, and experience as Assistant Editor of Gloss Magazine, Sarah brings real-world insight into performing under pressure in healthcare and beyond. Hosts Marissa O’Callaghan is an Irish-trained Respiratory Fellow currently undertaking a post-doc fellowship at Erasmus MC Rotterdam in the Netherlands. She completed Irish respiratory and internal medicine training and her PhD in 2025. Her interests include interstitial and rare lung diseases, clinical research, medical education, and medical innovation. Together with co-host Sandra Green, she founded the ITS podcast series in June 2024. Sandra Green is an Irish-trained respiratory doctor and climate advocate, and co-founder of Irish Doctors for the Environment. She holds an MSc in Leadership and Innovation in Healthcare from the Royal College of Surgeons Ireland (2023–2025). With Marissa, she co-founded the Irish Thoracic Society Podcast Productions in 2024 to share knowledge, insights, and innovation in respiratory care. Chapters: 00:00 – Navigating Career Development in Healthcare 01:56 – Understanding Professional Branding 09:37 – The Importance of Communication Skills 11:52 – Practical Steps for Building and Demonstrating Your Brand 14:19 – Communicating Technical Skills and Intentional Self-Promotion 18:23 – Staying Authentic While Adapting Your Brand 21:42 – Actionable Steps for Career Advancement Resources & Links - Sarah Geraghty – LinkedIn: https://ie.linkedin.com/in/sarah-geraghty-comms - The Communication Clinic: https://www.communicationsclinic.ie/ In this episode, Sarah Geraghty shares clear, practical strategies for healthcare professionals who want to advance their careers with intention. From defining your personal brand to building meaningful networks, this conversation focuses on reflection, self-awareness, and strategic action as the foundations of sustainable growth in a demanding field.


In this episode, we explore:

-The most common mistake in healthcare career planning: an unclear personal brand.

-How to define and communicate your professional brand effectively

- The importance of self-awareness and aligning your actions with your brand

- Practical steps to assess and close gaps between how you're perceived and how you want to be seen

- Balancing technical expertise with communication skills for career progression

- Customising your brand for different stakeholders and career stages

- Building meaningful, high-quality relationships over superficial connections

- The role of reflection and goal-setting in strategic career planning

- Staying authentic while adapting your persona to different professional contexts


Guest

Sarah Geraghty is Head of Careers at The Communications Clinics, specialising in high-stakes interview preparation and career transitions. A seasoned communication trainer and coach, she blends practical storytelling with leadership development to help professionals articulate their value clearly and confidently.

With a background in journalism and editorial work, including contributions to The Irish Times and The Journal, and experience as Assistant Editor of Gloss Magazine, Sarah brings real-world insight into performing under pressure in healthcare and beyond.


Hosts

Marissa O’Callaghan is an Irish-trained Respiratory Fellow currently undertaking a post-doc fellowship at Erasmus MC Rotterdam in the Netherlands. She completed Irish respiratory and internal medicine training and her PhD in 2025. Her interests include interstitial and rare lung diseases, clinical research, medical education, and medical innovation. Together with co-host Sandra Green, she founded the ITS podcast series in June 2024.


Sandra Green is an Irish-trained respiratory doctor and climate advocate, and co-founder of Irish Doctors for the Environment. She holds an MSc in Leadership and Innovation in Healthcare from the Royal College of Surgeons Ireland (2023–2025). With Marissa, she co-founded the Irish Thoracic Society Podcast Productions in 2024 to share knowledge, insights, and innovation in respiratory care.


Chapters:

00:00 – Navigating Career Development in Healthcare

01:56 – Understanding Professional Branding

09:37 – The Importance of Communication Skills

11:52 – Practical Steps for Building and Demonstrating Your Brand

14:19 – Communicating Technical Skills and Intentional Self-Promotion

18:23 – Staying Authentic While Adapting Your Brand

21:42 – Actionable Steps for Career Advancement


Resources & Links

- Sarah Geraghty – LinkedIn: https://ie.linkedin.com/in/sarah-geraghty-comms

- The Communication Clinic: https://www.communicationsclinic.ie/

]]> 1611 Inspire (Part 1) Mastering Healthcare Interviews: Strategies for Success with Sarah Geraghty Whether you’re preparing for a specialty registrar or consultant post—or are part of the wider respiratory multidisciplinary team—excelling in healthcare interviews requires clarity, authenticity, and strategic storytelling. In this episode, career and communication expert Sarah Geraghty shares practical guidance on standout interview preparation, avoiding common pitfalls, and clearly demonstrating your value. Prioritise evidence-based answers over generic statements Use the STAR framework (Situation, Task, Action, Result) to structure responses Practice speaking answers out loud rather than memorising scripts Address gaps or perceived weaknesses honestly and positively Align your unique experiences with the specific needs of the role Stay composed when faced with unfamiliar or unexpected questions Understand interviewer priorities and tailor responses accordingly Deliver a strong closing statement to reinforce suitability Leverage informal meetings and networking strategically Build a consistent professional brand and story bank for long-term success Sarah Geraghty Head of Careers at The Communications Clinic, specialising in high-stakes interview preparation and career transitions. A communication trainer and coach with a background in journalism and editorial work (Irish Times, The Journal, Assistant Editor of Gloss Magazine), Sarah brings real-world insight into performing under pressure and articulating professional value. Marissa O’Callaghan Irish-trained respiratory fellow and postdoctoral researcher at Erasmus MC, Rotterdam. Completed Irish respiratory and internal medicine training and a PhD in 2025. Interests include interstitial and rare lung diseases, clinical research, medical education, and healthcare innovation. Co-founder of the ITS Podcast Series (2024). Sandra Green Irish-trained respiratory doctor and climate advocate; co-founder of Irish Doctors for the Environment. Holds an MSc in Leadership and Innovation in Healthcare (RCSI, 2023–2025). Co-founder of Irish Thoracic Society Podcast Productions (2024). 00:00 – Introduction and episode overview 02:25 – Why speaking answers out loud matters 04:20 – Evidence over experience: thinking like an interviewer 06:15 – Building a targeted story bank 08:35 – Avoiding scripts and improving fluency 10:22 – Answering “Tell me about yourself” 13:09 – Structuring competency and scenario responses 18:03 – Addressing gaps and unfamiliar topics 24:23 – What to do when you don’t know an answer 27:49 – Demonstrating leadership and management skills 32:45 – Closing with impact 36:14 – Interview prep realities in busy clinical roles 56:55 – Differences in prep for SpR vs consultant roles 61:08 – Networking and informal meetings 63:43 – Crafting your professional brand Sarah Geraghty (LinkedIn): https://ie.linkedin.com/in/sarah-geraghty-comms The Communications Clinic: https://www.communicationsclinic.ie/ STAR Method: https://nationalcareers.service.gov.uk/careers-advice/interview-advice/the-star-method Wed, 04 Feb 2026 11:13:00 -0000 full The Podcast Studios Whether you’re preparing for a specialty registrar or consultant post—or are part of the wider respiratory multidisciplinary team—excelling in healthcare interviews requires clarity, authenticity, and strategic storytelling. In this episode, career and communication expert Sarah Geraghty shares practical guidance on standout interview preparation, avoiding common pitfalls, and clearly demonstrating your value. Prioritise evidence-based answers over generic statements Use the STAR framework (Situation, Task, Action, Result) to structure responses Practice speaking answers out loud rather than memorising scripts Address gaps or perceived weaknesses honestly and positively Align your unique experiences with the specific needs of the role Stay composed when faced with unfamiliar or unexpected questions Understand interviewer priorities and tailor responses accordingly Deliver a strong closing statement to reinforce suitability Leverage informal meetings and networking strategically Build a consistent professional brand and story bank for long-term success Sarah Geraghty Head of Careers at The Communications Clinic, specialising in high-stakes interview preparation and career transitions. A communication trainer and coach with a background in journalism and editorial work (Irish Times, The Journal, Assistant Editor of Gloss Magazine), Sarah brings real-world insight into performing under pressure and articulating professional value. Marissa O’Callaghan Irish-trained respiratory fellow and postdoctoral researcher at Erasmus MC, Rotterdam. Completed Irish respiratory and internal medicine training and a PhD in 2025. Interests include interstitial and rare lung diseases, clinical research, medical education, and healthcare innovation. Co-founder of the ITS Podcast Series (2024). Sandra Green Irish-trained respiratory doctor and climate advocate; co-founder of Irish Doctors for the Environment. Holds an MSc in Leadership and Innovation in Healthcare (RCSI, 2023–2025). Co-founder of Irish Thoracic Society Podcast Productions (2024). 00:00 – Introduction and episode overview 02:25 – Why speaking answers out loud matters 04:20 – Evidence over experience: thinking like an interviewer 06:15 – Building a targeted story bank 08:35 – Avoiding scripts and improving fluency 10:22 – Answering “Tell me about yourself” 13:09 – Structuring competency and scenario responses 18:03 – Addressing gaps and unfamiliar topics 24:23 – What to do when you don’t know an answer 27:49 – Demonstrating leadership and management skills 32:45 – Closing with impact 36:14 – Interview prep realities in busy clinical roles 56:55 – Differences in prep for SpR vs consultant roles 61:08 – Networking and informal meetings 63:43 – Crafting your professional brand Sarah Geraghty (LinkedIn): https://ie.linkedin.com/in/sarah-geraghty-comms The Communications Clinic: https://www.communicationsclinic.ie/ STAR Method: https://nationalcareers.service.gov.uk/careers-advice/interview-advice/the-star-method Whether you’re preparing for a specialty registrar or consultant post—or are part of the wider respiratory multidisciplinary team—excelling in healthcare interviews requires clarity, authenticity, and strategic storytelling. In this episode, career and communication expert Sarah Geraghty shares practical guidance on standout interview preparation, avoiding common pitfalls, and clearly demonstrating your value.

  • Prioritise evidence-based answers over generic statements

  • Use the STAR framework (Situation, Task, Action, Result) to structure responses

  • Practice speaking answers out loud rather than memorising scripts

  • Address gaps or perceived weaknesses honestly and positively

  • Align your unique experiences with the specific needs of the role

  • Stay composed when faced with unfamiliar or unexpected questions

  • Understand interviewer priorities and tailor responses accordingly

  • Deliver a strong closing statement to reinforce suitability

  • Leverage informal meetings and networking strategically

  • Build a consistent professional brand and story bank for long-term success

Sarah Geraghty Head of Careers at The Communications Clinic, specialising in high-stakes interview preparation and career transitions. A communication trainer and coach with a background in journalism and editorial work (Irish Times, The Journal, Assistant Editor of Gloss Magazine), Sarah brings real-world insight into performing under pressure and articulating professional value.


Marissa O’Callaghan Irish-trained respiratory fellow and postdoctoral researcher at Erasmus MC, Rotterdam. Completed Irish respiratory and internal medicine training and a PhD in 2025. Interests include interstitial and rare lung diseases, clinical research, medical education, and healthcare innovation. Co-founder of the ITS Podcast Series (2024).


Sandra Green Irish-trained respiratory doctor and climate advocate; co-founder of Irish Doctors for the Environment. Holds an MSc in Leadership and Innovation in Healthcare (RCSI, 2023–2025). Co-founder of Irish Thoracic Society Podcast Productions (2024).

  • 00:00 – Introduction and episode overview

  • 02:25 – Why speaking answers out loud matters

  • 04:20 – Evidence over experience: thinking like an interviewer

  • 06:15 – Building a targeted story bank

  • 08:35 – Avoiding scripts and improving fluency

  • 10:22 – Answering “Tell me about yourself”

  • 13:09 – Structuring competency and scenario responses

  • 18:03 – Addressing gaps and unfamiliar topics

  • 24:23 – What to do when you don’t know an answer

  • 27:49 – Demonstrating leadership and management skills

  • 32:45 – Closing with impact

  • 36:14 – Interview prep realities in busy clinical roles

  • 56:55 – Differences in prep for SpR vs consultant roles

  • 61:08 – Networking and informal meetings

  • 63:43 – Crafting your professional brand

]]> 3792 Inspire Part 2: Professor Luke Clancy: Clearing the Air - Evidence-Based Tobacco Control This episode features an evidence-based dialogue with Professor Luke Clancy on contemporary tobacco control. The discussion critically analyses tobacco's disease burden, cessation knowledge gaps in respiratory medicine, industry evolution toward novel nicotine products, adolescent neurodevelopmental risks of nicotine addiction, and missed opportunities in tobacco control during COVID-19. Listen to learn: The key health impacts of tobacco every respiratory MDT member must know. How the tobacco industry is using tech, AI, and synthetic nicotine to addict a new generation. Why framing e-cigarettes as "95% safer" was a public health disaster. The sobering lesson COVID-19 taught us about our priorities in tobacco control. Professor Clancy's one key message for making a difference in Ireland and beyond. Guest: Professor Luke Clancy, Director General of the TobaccoFree Research Institute Ireland, and a leading figure in Irish public health policy. Hosts: Margaret Higgins & Sandra Green Chapters: 00:00 - 01:32 | Introduction & Rapid-Fire Round 01:32 - 07:09 | Framing the harms of tobacco use 07:09 - 15:10 | The Formidable Tobacco Industry: Evolution & Tactics 15:10 - 20:31 | The Problem of Nicotine Addiction: E-Cigarettes & Harm Framing 20:31 - 25:07 | The COVID-19 Wake-Up Call & Missed Opportunities 25:07 - 27:02 | Conclusion & One Key Message Show Notes: ESPAD (European School Survey Project on Alcohol and Other Drugs): The long-running study tracking substance use in Irish and European youth. HSE Smoking Cessation Service: Praised by Clancy for doing "a great job, better than in many countries." TobaccoFree Research Institute Ireland (TFRI): Professor Clancy's institute. Irish Thoracic Society: Supporters of the Breathwork podcast. This episode is sponsored by AstraZeneca with no involvement in the input or content discussed. Produced with the support of the Irish Thoracic Society. For more, or to get involved, please use the links in the podcast description. Mon, 12 Jan 2026 08:29:00 -0000 full The Podcast Studios This episode features an evidence-based dialogue with Professor Luke Clancy on contemporary tobacco control. The discussion critically analyses tobacco's disease burden, cessation knowledge gaps in respiratory medicine, industry evolution toward novel nicotine products, adolescent neurodevelopmental risks of nicotine addiction, and missed opportunities in tobacco control during COVID-19. Listen to learn: The key health impacts of tobacco every respiratory MDT member must know. How the tobacco industry is using tech, AI, and synthetic nicotine to addict a new generation. Why framing e-cigarettes as "95% safer" was a public health disaster. The sobering lesson COVID-19 taught us about our priorities in tobacco control. Professor Clancy's one key message for making a difference in Ireland and beyond. Guest: Professor Luke Clancy, Director General of the TobaccoFree Research Institute Ireland, and a leading figure in Irish public health policy. Hosts: Margaret Higgins & Sandra Green Chapters: 00:00 - 01:32 | Introduction & Rapid-Fire Round 01:32 - 07:09 | Framing the harms of tobacco use 07:09 - 15:10 | The Formidable Tobacco Industry: Evolution & Tactics 15:10 - 20:31 | The Problem of Nicotine Addiction: E-Cigarettes & Harm Framing 20:31 - 25:07 | The COVID-19 Wake-Up Call & Missed Opportunities 25:07 - 27:02 | Conclusion & One Key Message Show Notes: ESPAD (European School Survey Project on Alcohol and Other Drugs): The long-running study tracking substance use in Irish and European youth. HSE Smoking Cessation Service: Praised by Clancy for doing "a great job, better than in many countries." TobaccoFree Research Institute Ireland (TFRI): Professor Clancy's institute. Irish Thoracic Society: Supporters of the Breathwork podcast. This episode is sponsored by AstraZeneca with no involvement in the input or content discussed. Produced with the support of the Irish Thoracic Society. For more, or to get involved, please use the links in the podcast description. This episode features an evidence-based dialogue with Professor Luke Clancy on contemporary tobacco control. The discussion critically analyses tobacco's disease burden, cessation knowledge gaps in respiratory medicine, industry evolution toward novel nicotine products, adolescent neurodevelopmental risks of nicotine addiction, and missed opportunities in tobacco control during COVID-19.

Listen to learn:

  • The key health impacts of tobacco every respiratory MDT member must know.

  • How the tobacco industry is using tech, AI, and synthetic nicotine to addict a new generation.

  • Why framing e-cigarettes as "95% safer" was a public health disaster.

  • The sobering lesson COVID-19 taught us about our priorities in tobacco control.

  • Professor Clancy's one key message for making a difference in Ireland and beyond.

Guest: Professor Luke Clancy, Director General of the TobaccoFree Research Institute Ireland, and a leading figure in Irish public health policy.

Hosts: Margaret Higgins & Sandra Green

Chapters:

00:00 - 01:32 | Introduction & Rapid-Fire Round

01:32 - 07:09 | Framing the harms of tobacco use

07:09 - 15:10 | The Formidable Tobacco Industry: Evolution & Tactics

15:10 - 20:31 | The Problem of Nicotine Addiction: E-Cigarettes & Harm Framing

20:31 - 25:07 | The COVID-19 Wake-Up Call & Missed Opportunities

25:07 - 27:02 | Conclusion & One Key Message


Show Notes:

  • ESPAD (European School Survey Project on Alcohol and Other Drugs): The long-running study tracking substance use in Irish and European youth.

  • HSE Smoking Cessation Service: Praised by Clancy for doing "a great job, better than in many countries."

  • TobaccoFree Research Institute Ireland (TFRI): Professor Clancy's institute.

  • Irish Thoracic Society: Supporters of the Breathwork podcast.

This episode is sponsored by AstraZeneca with no involvement in the input or content discussed. Produced with the support of the Irish Thoracic Society.

For more, or to get involved, please use the links in the podcast description.

]]> 1638 Breathwork: Demystifying Cardiopulmonary Exercise Testing (CPET) with Ciarán Heatley Join hosts Dr Margaret Higgins and Dr Marissa O’Callaghan as they sit down with respiratory physiology expert Ciarán Heatley to explore the science and clinical value of Cardiopulmonary Exercise Testing (CPET). Moving beyond static resting tests, this episode highlights how CPET provides dynamic, real-time insight into integrated cardiopulmonary, metabolic, and muscular responses to exercise. Ciarán, who leads the Respiratory Physiology Laboratory at Mater University Hospital Dublin, draws on over a decade of experience to explain what CPET truly measures and how it is applied in modern respiratory and cardiovascular care. The discussion covers CPET’s role in diagnosing unexplained dyspnoea, preoperative risk stratification, transplant assessment, pulmonary hypertension management, and personalised rehabilitation planning. Key Topics Covered 1. What CPET Really Measures CPET is more than a stress test—it evaluates ventilatory, cardiovascular, metabolic, and muscular responses during exercise. Core parameters discussed include VO₂ max, metabolic threshold (VT1), and respiratory compensation point (VT2), with emphasis on the distinction between aerobic capacity and functional capacity. 2. Clinical Applications CPET is valuable for: Investigating unexplained breathlessness Preoperative risk assessment for major surgery Heart and lung transplant evaluation Monitoring treatment response in pulmonary arterial hypertension Assessing pregnancy risk in congenital disease Individualised pulmonary rehabilitation planning 3. What the Test Involves A full CPET takes approximately 90 minutes, including setup, an 8–12 minute exercise phase, and interpretation. Bike ergometry is preferred clinically. Equipment includes ECG, spirometry, a metabolic mask, and continuous blood pressure monitoring. Safety protocols require two physiologists and one doctor present. 4. Interpreting CPET Data The episode breaks down: VT1 and VT2 identification Ventilatory efficiency (V̇E/V̇CO₂) Detection of V/Q mismatch and pulmonary hypertensionChronotropic incompetence and heart rate reserveVentilatory limitation vs maximum voluntary ventilationThe impact of obesity on interpretation 5. Referral Considerations Good referrals clearly state the clinical question, relevant comorbidities, and medications (especially beta-blockers). Contraindications include acute illness, recent MI, severe cognitive or mobility impairment, and significant claustrophobia. 6. CPET in Ireland CPET remains underutilised compared to the NHS, largely due to resource, training, and education gaps. However, there is growing recognition of respiratory physiology’s role within Irish healthcare. Educational Chapters 00:00 Introduction & disclaimer 03:28 What is CPET? 05:54 CPET procedure 09:32 Data interpretation 18:14 Clinical indications 22:51 Practical referrals 25:20 CPET in Ireland 29:32 Closing thoughts Further Learning ARTP CPET Course ERS Clinical Exercise Testing Course Cambridge CPET Course ATS/ACCP CPET Guidelines Wasserman’s Principles of Exercise Testing and Interpretation Guest: Ciarán Heatley, Chief II Respiratory Physiologist, Mater University Hospital Dublin Hosts: Dr Margaret Higgins & Dr Marissa O’Callaghan Disclaimer: Sponsored by AstraZeneca. Sponsor had no input into content. Always follow local clinical guidance. Mon, 29 Dec 2025 00:00:00 -0000 full The Podcast Studios Join hosts Dr Margaret Higgins and Dr Marissa O’Callaghan as they sit down with respiratory physiology expert Ciarán Heatley to explore the science and clinical value of Cardiopulmonary Exercise Testing (CPET). Moving beyond static resting tests, this episode highlights how CPET provides dynamic, real-time insight into integrated cardiopulmonary, metabolic, and muscular responses to exercise. Ciarán, who leads the Respiratory Physiology Laboratory at Mater University Hospital Dublin, draws on over a decade of experience to explain what CPET truly measures and how it is applied in modern respiratory and cardiovascular care. The discussion covers CPET’s role in diagnosing unexplained dyspnoea, preoperative risk stratification, transplant assessment, pulmonary hypertension management, and personalised rehabilitation planning. Key Topics Covered 1. What CPET Really Measures CPET is more than a stress test—it evaluates ventilatory, cardiovascular, metabolic, and muscular responses during exercise. Core parameters discussed include VO₂ max, metabolic threshold (VT1), and respiratory compensation point (VT2), with emphasis on the distinction between aerobic capacity and functional capacity. 2. Clinical Applications CPET is valuable for: Investigating unexplained breathlessness Preoperative risk assessment for major surgery Heart and lung transplant evaluation Monitoring treatment response in pulmonary arterial hypertension Assessing pregnancy risk in congenital disease Individualised pulmonary rehabilitation planning 3. What the Test Involves A full CPET takes approximately 90 minutes, including setup, an 8–12 minute exercise phase, and interpretation. Bike ergometry is preferred clinically. Equipment includes ECG, spirometry, a metabolic mask, and continuous blood pressure monitoring. Safety protocols require two physiologists and one doctor present. 4. Interpreting CPET Data The episode breaks down: VT1 and VT2 identification Ventilatory efficiency (V̇E/V̇CO₂) Detection of V/Q mismatch and pulmonary hypertensionChronotropic incompetence and heart rate reserveVentilatory limitation vs maximum voluntary ventilationThe impact of obesity on interpretation 5. Referral Considerations Good referrals clearly state the clinical question, relevant comorbidities, and medications (especially beta-blockers). Contraindications include acute illness, recent MI, severe cognitive or mobility impairment, and significant claustrophobia. 6. CPET in Ireland CPET remains underutilised compared to the NHS, largely due to resource, training, and education gaps. However, there is growing recognition of respiratory physiology’s role within Irish healthcare. Educational Chapters 00:00 Introduction & disclaimer 03:28 What is CPET? 05:54 CPET procedure 09:32 Data interpretation 18:14 Clinical indications 22:51 Practical referrals 25:20 CPET in Ireland 29:32 Closing thoughts Further Learning ARTP CPET Course ERS Clinical Exercise Testing Course Cambridge CPET Course ATS/ACCP CPET Guidelines Wasserman’s Principles of Exercise Testing and Interpretation Guest: Ciarán Heatley, Chief II Respiratory Physiologist, Mater University Hospital Dublin Hosts: Dr Margaret Higgins & Dr Marissa O’Callaghan Disclaimer: Sponsored by AstraZeneca. Sponsor had no input into content. Always follow local clinical guidance. Join hosts Dr Margaret Higgins and Dr Marissa O’Callaghan as they sit down with respiratory physiology expert Ciarán Heatley to explore the science and clinical value of Cardiopulmonary Exercise Testing (CPET). Moving beyond static resting tests, this episode highlights how CPET provides dynamic, real-time insight into integrated cardiopulmonary, metabolic, and muscular responses to exercise.

Ciarán, who leads the Respiratory Physiology Laboratory at Mater University Hospital Dublin, draws on over a decade of experience to explain what CPET truly measures and how it is applied in modern respiratory and cardiovascular care. The discussion covers CPET’s role in diagnosing unexplained dyspnoea, preoperative risk stratification, transplant assessment, pulmonary hypertension management, and personalised rehabilitation planning.


Key Topics Covered

1. What CPET Really Measures

CPET is more than a stress test—it evaluates ventilatory, cardiovascular, metabolic, and muscular responses during exercise. Core parameters discussed include VO₂ max, metabolic threshold (VT1), and respiratory compensation point (VT2), with emphasis on the distinction between aerobic capacity and functional capacity.


2. Clinical Applications

CPET is valuable for:

Investigating unexplained breathlessness Preoperative risk assessment for major surgery Heart and lung transplant evaluation Monitoring treatment response in pulmonary arterial hypertension Assessing pregnancy risk in congenital disease Individualised pulmonary rehabilitation planning


3. What the Test Involves

A full CPET takes approximately 90 minutes, including setup, an 8–12 minute exercise phase, and interpretation. Bike ergometry is preferred clinically. Equipment includes ECG, spirometry, a metabolic mask, and continuous blood pressure monitoring. Safety protocols require two physiologists and one doctor present.


4. Interpreting CPET Data

The episode breaks down:

VT1 and VT2 identification Ventilatory efficiency (V̇E/V̇CO₂) Detection of V/Q mismatch and pulmonary hypertensionChronotropic incompetence and heart rate reserveVentilatory limitation vs maximum voluntary ventilationThe impact of obesity on interpretation


5. Referral Considerations

Good referrals clearly state the clinical question, relevant comorbidities, and medications (especially beta-blockers). Contraindications include acute illness, recent MI, severe cognitive or mobility impairment, and significant claustrophobia.


6. CPET in Ireland

CPET remains underutilised compared to the NHS, largely due to resource, training, and education gaps. However, there is growing recognition of respiratory physiology’s role within Irish healthcare.


Educational Chapters

00:00 Introduction & disclaimer

03:28 What is CPET?

05:54 CPET procedure

09:32 Data interpretation

18:14 Clinical indications

22:51 Practical referrals

25:20 CPET in Ireland

29:32 Closing thoughts


Further Learning

ARTP CPET Course

ERS Clinical Exercise Testing Course

Cambridge CPET Course

ATS/ACCP CPET Guidelines


Wasserman’s Principles of Exercise Testing and Interpretation


Guest: Ciarán Heatley, Chief II Respiratory Physiologist, Mater University Hospital Dublin

Hosts: Dr Margaret Higgins & Dr Marissa O’Callaghan


Disclaimer: Sponsored by AstraZeneca. Sponsor had no input into content. Always follow local clinical guidance.

]]> 1809 Inspire — Professor Luke Clancy: From innovations in clinical care to national policy Professor Luke Clancy, Director General of the Tobacco Free Research Institute Ireland and Professor at Technological University Dublin, describes how clinical observation, focused research and coalition‑building translated into major public‑health wins — the 1990 Dublin smoky‑coal ban and Ireland’s 2004 Public Health (Tobacco) Act. He reflects on the science behind excess winter mortality and air pollution, clinical innovations (bronchoscopy, COPD outreach, lung‑cancer MDTs), tobacco control advocacy, implementation lessons and leadership advice for clinicians to influence policy.   Chapters 00:00 — Introduction & guest bio 01:12 — Why clinicians should turn observation into research 01:41 — Early training, influences and clinical work 04:38 — Dublin smog: excess winter mortality & particle debate 08:01 — Publishing the evidence & getting external support 08:58 — Politics & the path to the Smoky Coal ban 11:09 — Why national rollout took decades 15:36 — Tobacco control: forming ASH & building strategy 20:04 — Coalition building, unions & the 2004 Public Health (Tobacco) Act 23:21 — International influence & lessons 24:42 — Clinical innovations: bronchoscopy, COPD, lung cancer services 27:30 — Leadership lessons for clinician‑advocates 28:46 — Wrap up & next episode preview 28:56 — End   Show notes • Kelly, I., Clancy, L. et al., 1984. Mortality in a general hospital and urban air pollution. ResearchGate. [online] (Accessed 14 December 2025) • Tobacco Free Research Institute Ireland (TFRI) https://www.tri.ie/ • Action on Smoking and Health (ASH) Ireland https://ash.ie/ • Framework Convention on Tobacco Control https://fctc.who.int/convention Mon, 15 Dec 2025 17:19:00 -0000 full The Podcast Studios Professor Luke Clancy, Director General of the Tobacco Free Research Institute Ireland and Professor at Technological University Dublin, describes how clinical observation, focused research and coalition‑building translated into major public‑health wins — the 1990 Dublin smoky‑coal ban and Ireland’s 2004 Public Health (Tobacco) Act. He reflects on the science behind excess winter mortality and air pollution, clinical innovations (bronchoscopy, COPD outreach, lung‑cancer MDTs), tobacco control advocacy, implementation lessons and leadership advice for clinicians to influence policy.   Chapters 00:00 — Introduction & guest bio 01:12 — Why clinicians should turn observation into research 01:41 — Early training, influences and clinical work 04:38 — Dublin smog: excess winter mortality & particle debate 08:01 — Publishing the evidence & getting external support 08:58 — Politics & the path to the Smoky Coal ban 11:09 — Why national rollout took decades 15:36 — Tobacco control: forming ASH & building strategy 20:04 — Coalition building, unions & the 2004 Public Health (Tobacco) Act 23:21 — International influence & lessons 24:42 — Clinical innovations: bronchoscopy, COPD, lung cancer services 27:30 — Leadership lessons for clinician‑advocates 28:46 — Wrap up & next episode preview 28:56 — End   Show notes • Kelly, I., Clancy, L. et al., 1984. Mortality in a general hospital and urban air pollution. ResearchGate. [online] (Accessed 14 December 2025) • Tobacco Free Research Institute Ireland (TFRI) https://www.tri.ie/ • Action on Smoking and Health (ASH) Ireland https://ash.ie/ • Framework Convention on Tobacco Control https://fctc.who.int/convention Professor Luke Clancy, Director General of the Tobacco Free Research Institute Ireland and Professor at Technological University Dublin, describes how clinical observation, focused research and coalition‑building translated into major public‑health wins — the 1990 Dublin smoky‑coal ban and Ireland’s 2004 Public Health (Tobacco) Act.

He reflects on the science behind excess winter mortality and air pollution, clinical innovations (bronchoscopy, COPD outreach, lung‑cancer MDTs), tobacco control advocacy, implementation lessons and leadership advice for clinicians to influence policy.

 

Chapters

00:00 — Introduction & guest bio
01:12 — Why clinicians should turn observation into research
01:41 — Early training, influences and clinical work
04:38 — Dublin smog: excess winter mortality & particle debate
08:01 — Publishing the evidence & getting external support
08:58 — Politics & the path to the Smoky Coal ban
11:09 — Why national rollout took decades
15:36 — Tobacco control: forming ASH & building strategy
20:04 — Coalition building, unions & the 2004 Public Health (Tobacco) Act
23:21 — International influence & lessons
24:42 — Clinical innovations: bronchoscopy, COPD, lung cancer services
27:30 — Leadership lessons for clinician‑advocates
28:46 — Wrap up & next episode preview
28:56 — End

 

Show notes

• Kelly, I., Clancy, L. et al., 1984. Mortality in a general hospital and urban air pollution. ResearchGate. [online] (Accessed 14 December 2025)

• Tobacco Free Research Institute Ireland (TFRI) https://www.tri.ie/

• Action on Smoking and Health (ASH) Ireland https://ash.ie/

• Framework Convention on Tobacco Control https://fctc.who.int/convention


]]> 1657 Breathwork: Digital Asthma Management with Professor Richard Costello In this episode, Irish respiratory fellows Barry and Sandra sit down with Professor Richard Costello to explore the rapidly evolving world of digital asthma care. From eosinophils and T2 inflammation to the future of smart inhalers and precision monitoring, this conversation dives deep into how technology is reshaping diagnosis, adherence, and long-term management. Professor Richard Costello discusses the challenges of diagnosing a highly variable disease, the limitations of symptom-based tools like the ACT, and why biomarkers and digital home spirometry are essential in modern asthma practice. They cover how digital devices can reveal patient behaviour, uncover hidden comorbidities, and distinguish difficult-to-treat asthma from true severe asthma. The episode also explores the emerging potential of closed-loop smart inhalers, real-time lung function monitoring, and how personalised dosing may soon become a reality. Along the way, the team unpacks overlooked side effects of chronic inhaled steroids, the importance of steroid stewardship, and how Ireland can move toward a more decentralised, digitally enabled model of asthma care. Chapters 00:00 – Introduction 00:31 – Episode Overview 01:15 – Rapid-Fire Round: True or False 03:45 – The Importance of Eosinophils & T2 InflammationDr. Costello explains why identifying T2 inflammation is central to diagnosing and managing asthma. 06:15 – Challenges in Diagnosing AsthmaVariability, biomarkers, bronchial responsiveness, and why asthma remains difficult to diagnose in 2025. 09:40 – The Role of Home SpirometryHow home monitoring helps differentiate asthma from mimics and guides treatment decisions. 12:10 – Differentiating Difficult-to-Treat vs Severe AsthmaUsing digital adherence data to distinguish true severity from difficult to treat asthma. 14:20 – The Future: Smart, Closed-Loop InhalersHow inhalers may soon auto-dose based on real-time airflow and physiology. 17:00 – Understanding the User, Not Just the DeviceDigital data reveals patient behaviour patterns and barriers to adherence. 20:10 – When Symptoms Aren’t AsthmaReflux, deconditioning, cardiac disease, and other asthma mimics uncovered through monitoring. 22:20 – Hidden Side Effects of High-Dose SteroidsAdrenal suppression, cataracts, diabetes, and why symptom-based escalation can lead to elevated steroid exposure. 25:00 – The Limitations of the ACT & Symptom ScoresWhy subjective questionnaires fall short in a multimorbid population. 27:10 – Ireland’s Future: Digital Home Monitoring & Decentralised CareHow integrated hubs and digital platforms could streamline diagnosis and management. 30:00 – Looking Ahead 31:29 – Closing Remarks Guest: Professor Richard Costello Professor Richard Costello is a professor of respiratory medicine at the Royal College of Surgeons in Ireland and a consultant at Beaumont Hospital, Dublin. He trained at RCSI, Beaumont, and Johns Hopkins University. A leading researcher in airways disease and digital respiratory health, he has published over 200 papers, holds several health innovation patents, and founded a company focused on inhaler adherence. He has served as Vice President of the Royal College of Physicians of Ireland and chaired the European Respiratory Society Educational Council, receiving the ERS Educational Award for his contributions to respiratory medicine.   Hosts: Dr Barry Harnedy & Dr Sandra Green Dr Barry Harnedy is a respiratory specialist trainee in Ireland. He graduated from National University of Ireland Galway. He is the current Irish Thoracic Society co Educational Officer. He is passionate about digital innovation and airways assessment.  Dr Sandra Green is a respiratory specialist trainee in Ireland. She is the current Irish Thoracic Society Sustainability Officer. As a founder of Irish Doctors for the Environment she is interested in healthcare sustainability and planetary health.  Tue, 02 Dec 2025 14:49:00 -0000 full The Podcast Studios In this episode, Irish respiratory fellows Barry and Sandra sit down with Professor Richard Costello to explore the rapidly evolving world of digital asthma care. From eosinophils and T2 inflammation to the future of smart inhalers and precision monitoring, this conversation dives deep into how technology is reshaping diagnosis, adherence, and long-term management. Professor Richard Costello discusses the challenges of diagnosing a highly variable disease, the limitations of symptom-based tools like the ACT, and why biomarkers and digital home spirometry are essential in modern asthma practice. They cover how digital devices can reveal patient behaviour, uncover hidden comorbidities, and distinguish difficult-to-treat asthma from true severe asthma. The episode also explores the emerging potential of closed-loop smart inhalers, real-time lung function monitoring, and how personalised dosing may soon become a reality. Along the way, the team unpacks overlooked side effects of chronic inhaled steroids, the importance of steroid stewardship, and how Ireland can move toward a more decentralised, digitally enabled model of asthma care. Chapters 00:00 – Introduction 00:31 – Episode Overview 01:15 – Rapid-Fire Round: True or False 03:45 – The Importance of Eosinophils & T2 InflammationDr. Costello explains why identifying T2 inflammation is central to diagnosing and managing asthma. 06:15 – Challenges in Diagnosing AsthmaVariability, biomarkers, bronchial responsiveness, and why asthma remains difficult to diagnose in 2025. 09:40 – The Role of Home SpirometryHow home monitoring helps differentiate asthma from mimics and guides treatment decisions. 12:10 – Differentiating Difficult-to-Treat vs Severe AsthmaUsing digital adherence data to distinguish true severity from difficult to treat asthma. 14:20 – The Future: Smart, Closed-Loop InhalersHow inhalers may soon auto-dose based on real-time airflow and physiology. 17:00 – Understanding the User, Not Just the DeviceDigital data reveals patient behaviour patterns and barriers to adherence. 20:10 – When Symptoms Aren’t AsthmaReflux, deconditioning, cardiac disease, and other asthma mimics uncovered through monitoring. 22:20 – Hidden Side Effects of High-Dose SteroidsAdrenal suppression, cataracts, diabetes, and why symptom-based escalation can lead to elevated steroid exposure. 25:00 – The Limitations of the ACT & Symptom ScoresWhy subjective questionnaires fall short in a multimorbid population. 27:10 – Ireland’s Future: Digital Home Monitoring & Decentralised CareHow integrated hubs and digital platforms could streamline diagnosis and management. 30:00 – Looking Ahead 31:29 – Closing Remarks Guest: Professor Richard Costello Professor Richard Costello is a professor of respiratory medicine at the Royal College of Surgeons in Ireland and a consultant at Beaumont Hospital, Dublin. He trained at RCSI, Beaumont, and Johns Hopkins University. A leading researcher in airways disease and digital respiratory health, he has published over 200 papers, holds several health innovation patents, and founded a company focused on inhaler adherence. He has served as Vice President of the Royal College of Physicians of Ireland and chaired the European Respiratory Society Educational Council, receiving the ERS Educational Award for his contributions to respiratory medicine.   Hosts: Dr Barry Harnedy & Dr Sandra Green Dr Barry Harnedy is a respiratory specialist trainee in Ireland. He graduated from National University of Ireland Galway. He is the current Irish Thoracic Society co Educational Officer. He is passionate about digital innovation and airways assessment.  Dr Sandra Green is a respiratory specialist trainee in Ireland. She is the current Irish Thoracic Society Sustainability Officer. As a founder of Irish Doctors for the Environment she is interested in healthcare sustainability and planetary health.  In this episode, Irish respiratory fellows Barry and Sandra sit down with Professor Richard Costello to explore the rapidly evolving world of digital asthma care. From eosinophils and T2 inflammation to the future of smart inhalers and precision monitoring, this conversation dives deep into how technology is reshaping diagnosis, adherence, and long-term management.

Professor Richard Costello discusses the challenges of diagnosing a highly variable disease, the limitations of symptom-based tools like the ACT, and why biomarkers and digital home spirometry are essential in modern asthma practice. They cover how digital devices can reveal patient behaviour, uncover hidden comorbidities, and distinguish difficult-to-treat asthma from true severe asthma.

The episode also explores the emerging potential of closed-loop smart inhalers, real-time lung function monitoring, and how personalised dosing may soon become a reality. Along the way, the team unpacks overlooked side effects of chronic inhaled steroids, the importance of steroid stewardship, and how Ireland can move toward a more decentralised, digitally enabled model of asthma care.


Chapters

00:00 – Introduction

00:31 – Episode Overview

01:15 – Rapid-Fire Round: True or False

03:45 – The Importance of Eosinophils & T2 Inflammation
Dr. Costello explains why identifying T2 inflammation is central to diagnosing and managing asthma.

06:15 – Challenges in Diagnosing Asthma
Variability, biomarkers, bronchial responsiveness, and why asthma remains difficult to diagnose in 2025.

09:40 – The Role of Home Spirometry
How home monitoring helps differentiate asthma from mimics and guides treatment decisions.

12:10 – Differentiating Difficult-to-Treat vs Severe Asthma
Using digital adherence data to distinguish true severity from difficult to treat asthma.

14:20 – The Future: Smart, Closed-Loop Inhalers
How inhalers may soon auto-dose based on real-time airflow and physiology.

17:00 – Understanding the User, Not Just the Device
Digital data reveals patient behaviour patterns and barriers to adherence.

20:10 – When Symptoms Aren’t Asthma
Reflux, deconditioning, cardiac disease, and other asthma mimics uncovered through monitoring.

22:20 – Hidden Side Effects of High-Dose Steroids
Adrenal suppression, cataracts, diabetes, and why symptom-based escalation can lead to elevated steroid exposure.

25:00 – The Limitations of the ACT & Symptom Scores
Why subjective questionnaires fall short in a multimorbid population.

27:10 – Ireland’s Future: Digital Home Monitoring & Decentralised Care
How integrated hubs and digital platforms could streamline diagnosis and management.

30:00 – Looking Ahead

31:29 – Closing Remarks


Guest: Professor Richard Costello

Professor Richard Costello is a professor of respiratory medicine at the Royal College of Surgeons in Ireland and a consultant at Beaumont Hospital, Dublin. He trained at RCSI, Beaumont, and Johns Hopkins University. A leading researcher in airways disease and digital respiratory health, he has published over 200 papers, holds several health innovation patents, and founded a company focused on inhaler adherence. He has served as Vice President of the Royal College of Physicians of Ireland and chaired the European Respiratory Society Educational Council, receiving the ERS Educational Award for his contributions to respiratory medicine.  

Hosts: Dr Barry Harnedy & Dr Sandra Green

  • Dr Barry Harnedy is a respiratory specialist trainee in Ireland. He graduated from National University of Ireland Galway. He is the current Irish Thoracic Society co Educational Officer. He is passionate about digital innovation and airways assessment. 
  • Dr Sandra Green is a respiratory specialist trainee in Ireland. She is the current Irish Thoracic Society Sustainability Officer. As a founder of Irish Doctors for the Environment she is interested in healthcare sustainability and planetary health. 
]]> 1621 Inspire: Digital health and setting up a medical device with Professor Richard Costello We’re back in the studio with Professor Richard Costello, exploring his vision for the future of digital health and what it takes to set up a medical device to life. He discusses how his experience in digital monitoring led him to a deeper understanding of human behaviour. 00:00 Intro and episode overview 00:41 Introduction to Professor Richard Costello 02:13 Developing an interest in digital health 04:49 Developing patents in digital health 08:37 Maintaining motivation 10:17 Challenges setting up a medical device 13:24 Vision for digital health 16:26 Restructuring healthcare to be more inclusive using digital technology 16:49 Data ownership in digital health 17:33 Portals of communication and the electronic healthcare record 19:44 GDPR in digital health 21:29 Funding structures for digital subscriptions and online platforms 23:19 Inequality and inclusion in the digital era 23:59 The carbon footprint of digital health Guest - Professor Richard Costello Professor Richard Costello is a professor of respiratory medicine at the Royal College of Surgeons in Ireland and a consultant at Beaumont Hospital, Dublin. He trained at RCSI, Beaumont, and Johns Hopkins University. A leading researcher in airways disease and digital respiratory health, he has published over 200 papers, holds several health innovation patents, and founded a company focused on inhaler adherence. He has served as Vice President of the Royal College of Physicians of Ireland and chaired the European Respiratory Society Educational Council, receiving the ERS Educational Award for his contributions to respiratory medicine. Hosts - Dr Barry Harnedy & Dr Sandra Green Dr Barry Harnedy is a respiratory specialist trainee in Ireland. He graduated from National University of Ireland Galway. He is the current Irish Thoracic Society co Educational Officer. He is passionate about digital innovation and airways assessment. Dr Sandra Green is a respiratory specialist trainee in Ireland. She is the current Irish Thoracic Society Sustainability Officer. As a founder of Irish Doctors for the Environment she is interested in healthcare sustainability and planetary health. Mon, 17 Nov 2025 05:00:00 -0000 full The Podcast Studios We’re back in the studio with Professor Richard Costello, exploring his vision for the future of digital health and what it takes to set up a medical device to life. He discusses how his experience in digital monitoring led him to a deeper understanding of human behaviour. 00:00 Intro and episode overview 00:41 Introduction to Professor Richard Costello 02:13 Developing an interest in digital health 04:49 Developing patents in digital health 08:37 Maintaining motivation 10:17 Challenges setting up a medical device 13:24 Vision for digital health 16:26 Restructuring healthcare to be more inclusive using digital technology 16:49 Data ownership in digital health 17:33 Portals of communication and the electronic healthcare record 19:44 GDPR in digital health 21:29 Funding structures for digital subscriptions and online platforms 23:19 Inequality and inclusion in the digital era 23:59 The carbon footprint of digital health Guest - Professor Richard Costello Professor Richard Costello is a professor of respiratory medicine at the Royal College of Surgeons in Ireland and a consultant at Beaumont Hospital, Dublin. He trained at RCSI, Beaumont, and Johns Hopkins University. A leading researcher in airways disease and digital respiratory health, he has published over 200 papers, holds several health innovation patents, and founded a company focused on inhaler adherence. He has served as Vice President of the Royal College of Physicians of Ireland and chaired the European Respiratory Society Educational Council, receiving the ERS Educational Award for his contributions to respiratory medicine. Hosts - Dr Barry Harnedy & Dr Sandra Green Dr Barry Harnedy is a respiratory specialist trainee in Ireland. He graduated from National University of Ireland Galway. He is the current Irish Thoracic Society co Educational Officer. He is passionate about digital innovation and airways assessment. Dr Sandra Green is a respiratory specialist trainee in Ireland. She is the current Irish Thoracic Society Sustainability Officer. As a founder of Irish Doctors for the Environment she is interested in healthcare sustainability and planetary health. We’re back in the studio with Professor Richard Costello, exploring his vision for the future of digital health and what it takes to set up a medical device to life. He discusses how his experience in digital monitoring led him to a deeper understanding of human behaviour.

00:00 Intro and episode overview
00:41 Introduction to Professor Richard Costello
02:13 Developing an interest in digital health
04:49 Developing patents in digital health
08:37 Maintaining motivation
10:17 Challenges setting up a medical device
13:24 Vision for digital health
16:26 Restructuring healthcare to be more inclusive using digital technology
16:49 Data ownership in digital health
17:33 Portals of communication and the electronic healthcare record
19:44 GDPR in digital health
21:29 Funding structures for digital subscriptions and online platforms
23:19 Inequality and inclusion in the digital era
23:59 The carbon footprint of digital health

Guest - Professor Richard Costello

Professor Richard Costello is a professor of respiratory medicine at the Royal College of Surgeons in Ireland and a consultant at Beaumont Hospital, Dublin. He trained at RCSI, Beaumont, and Johns Hopkins University. A leading researcher in airways disease and digital respiratory health, he has published over 200 papers, holds several health innovation patents, and founded a company focused on inhaler adherence. He has served as Vice President of the Royal College of Physicians of Ireland and chaired the European Respiratory Society Educational Council, receiving the ERS Educational Award for his contributions to respiratory medicine.



Hosts - Dr Barry Harnedy & Dr Sandra Green

Dr Barry Harnedy is a respiratory specialist trainee in Ireland. He graduated from National University of Ireland Galway. He is the current Irish Thoracic Society co Educational Officer. He is passionate about digital innovation and airways assessment.


Dr Sandra Green is a respiratory specialist trainee in Ireland. She is the current Irish Thoracic Society Sustainability Officer. As a founder of Irish Doctors for the Environment she is interested in healthcare sustainability and planetary health.

]]> 1674 Preparing for the European Respiratory Society Congress 2025, advice from early career representatives In this episode, Dr Marissa O’Callaghan and Dr Sandra Green host Dr. Augusta Beach and Dr. Laura Fabbri, both Early Career Representatives of the European Respiratory Society. They discuss their journeys to becoming representatives, the responsibilities of their roles, and the importance of networking and engagement within the society. This conversation also focuses on the upcoming Congress, including key sessions, tips for poster presentations, and social events, emphasizing the value of participation and proactive involvement for early career members. Keywords European Respiratory Society, Early Career Representatives, Networking, Congress, ILD, COPD, Research, Eosinophils, Asthma, Clinical Trials Mon, 22 Sep 2025 15:29:00 -0000 full The Podcast Studios In this episode, Dr Marissa O’Callaghan and Dr Sandra Green host Dr. Augusta Beach and Dr. Laura Fabbri, both Early Career Representatives of the European Respiratory Society. They discuss their journeys to becoming representatives, the responsibilities of their roles, and the importance of networking and engagement within the society. This conversation also focuses on the upcoming Congress, including key sessions, tips for poster presentations, and social events, emphasizing the value of participation and proactive involvement for early career members. Keywords European Respiratory Society, Early Career Representatives, Networking, Congress, ILD, COPD, Research, Eosinophils, Asthma, Clinical Trials In this episode, Dr Marissa O’Callaghan and Dr Sandra Green host Dr. Augusta Beach and Dr. Laura Fabbri, both Early Career Representatives of the European Respiratory Society.

They discuss their journeys to becoming representatives, the responsibilities of their roles, and the importance of networking and engagement within the society.

This conversation also focuses on the upcoming Congress, including key sessions, tips for poster presentations, and social events, emphasizing the value of participation and proactive involvement for early career members.


Keywords

European Respiratory Society, Early Career Representatives, Networking, Congress, ILD, COPD, Research, Eosinophils, Asthma, Clinical Trials

]]> 1935 Conference Series: Maximizing Your European Respiratory Society Congress 2025 Experience with Dr Barry Harnedy and Dr Margaret Higgins (Part 1) In this episode, Dr Marissa O'Callaghan and Dr Sandra Green host Dr. Margaret Higgins and Dr. Barry Harnedy, the new Educational Officers of the Irish Thoracic Society, to discuss the upcoming ERS Congress in Amsterdam. They share insights on how to strategies to get the most out of your conference attendance, the importance of networking, and opportunities for pursuing fellowships. The conversation also includes a fun quiz about the ERS Congress and practical tips for first-time attendees. Keyword / Tags ERS Congress, networking, fellowship, pulmonology, education, conference tips, respiratory health, international collaboration, poster sessions, early career Mon, 15 Sep 2025 09:04:00 -0000 full The Podcast Studios In this episode, Dr Marissa O'Callaghan and Dr Sandra Green host Dr. Margaret Higgins and Dr. Barry Harnedy, the new Educational Officers of the Irish Thoracic Society, to discuss the upcoming ERS Congress in Amsterdam. They share insights on how to strategies to get the most out of your conference attendance, the importance of networking, and opportunities for pursuing fellowships. The conversation also includes a fun quiz about the ERS Congress and practical tips for first-time attendees. Keyword / Tags ERS Congress, networking, fellowship, pulmonology, education, conference tips, respiratory health, international collaboration, poster sessions, early career In this episode, Dr Marissa O'Callaghan and Dr Sandra Green host Dr. Margaret Higgins and Dr. Barry Harnedy, the new Educational Officers of the Irish Thoracic Society, to discuss the upcoming ERS Congress in Amsterdam. They share insights on how to strategies to get the most out of your conference attendance, the importance of networking, and opportunities for pursuing fellowships. The conversation also includes a fun quiz about the ERS Congress and practical tips for first-time attendees.


Keyword / Tags

ERS Congress, networking, fellowship, pulmonology, education, conference tips, respiratory health, international collaboration, poster sessions, early career

]]> 1336 Breathwork: Overview of lung function testing and the new Global Lung Initiative Guidelines with Aisling McGowan (Part 2) In this episode, Aisling McGowan takes us through the full journey of lung function testing — from referral to patient walkthrough — covering contraindications, the patient experience, and interpretation using the new GLI Guidelines. Mon, 01 Sep 2025 14:33:00 -0000 full The Podcast Studios In this episode, Aisling McGowan takes us through the full journey of lung function testing — from referral to patient walkthrough — covering contraindications, the patient experience, and interpretation using the new GLI Guidelines. In this episode, Aisling McGowan takes us through the full journey of lung function testing — from referral to patient walkthrough — covering contraindications, the patient experience, and interpretation using the new GLI Guidelines.

]]> 1611 Inspire: Respiratory Physiology: Career Insights with Aisling McGowan (Part 1) Join us in this interview with Aisling McGowan, Chief 2 Physiologist at Connolly Hospital, Dublin, whose 34-year career in respiratory and sleep diagnostics has combined clinical expertise, education, and leadership. We explore the role of a respiratory physiologist, the varied training paths into the profession, career progression, opportunities in education and leadership, and the challenges and rewards of a career in respiratory physiology in Ireland. 01:10 Describing the role of the respiratory physiologist 03:13 The training pathway for respiratory physiology 06:32 Specialising in respiratory physiology 08:10 Postgraduate entry to respiratory physiology 08:50 Career progression; staff grade to senior to chief one and chief two 12:10 Advanced practice in respiratory physiology 13:53 Changes to the role if advanced practice came into effect 14:45 Opportunities abroad for Irish trainees 15:50 The pathway for internationally trained respiratory physiologists 16:20 Popularity of respiratory physiology degree courses 17:09 Challenges in recruitment and retention 17:50 Additional postgraduate training opportunities: Master of Science 20:10 Staff shortages and workloads 21:45 The impact of integrated community care hubs on tertiary care staffing 22:26 Vision for lung function diagnostics in the integrated care hub 27:18 What keeps you engaged? Mon, 18 Aug 2025 08:11:00 -0000 full The Podcast Studios Join us in this interview with Aisling McGowan, Chief 2 Physiologist at Connolly Hospital, Dublin, whose 34-year career in respiratory and sleep diagnostics has combined clinical expertise, education, and leadership. We explore the role of a respiratory physiologist, the varied training paths into the profession, career progression, opportunities in education and leadership, and the challenges and rewards of a career in respiratory physiology in Ireland. 01:10 Describing the role of the respiratory physiologist 03:13 The training pathway for respiratory physiology 06:32 Specialising in respiratory physiology 08:10 Postgraduate entry to respiratory physiology 08:50 Career progression; staff grade to senior to chief one and chief two 12:10 Advanced practice in respiratory physiology 13:53 Changes to the role if advanced practice came into effect 14:45 Opportunities abroad for Irish trainees 15:50 The pathway for internationally trained respiratory physiologists 16:20 Popularity of respiratory physiology degree courses 17:09 Challenges in recruitment and retention 17:50 Additional postgraduate training opportunities: Master of Science 20:10 Staff shortages and workloads 21:45 The impact of integrated community care hubs on tertiary care staffing 22:26 Vision for lung function diagnostics in the integrated care hub 27:18 What keeps you engaged? Join us in this interview with Aisling McGowan, Chief 2 Physiologist at Connolly Hospital, Dublin, whose 34-year career in respiratory and sleep diagnostics has combined clinical expertise, education, and leadership. We explore the role of a respiratory physiologist, the varied training paths into the profession, career progression, opportunities in education and leadership, and the challenges and rewards of a career in respiratory physiology in Ireland.

  • 01:10 Describing the role of the respiratory physiologist

  • 03:13 The training pathway for respiratory physiology

  • 06:32 Specialising in respiratory physiology

  • 08:10 Postgraduate entry to respiratory physiology

  • 08:50 Career progression; staff grade to senior to chief one and chief two

  • 12:10 Advanced practice in respiratory physiology

  • 13:53 Changes to the role if advanced practice came into effect

  • 14:45 Opportunities abroad for Irish trainees

  • 15:50 The pathway for internationally trained respiratory physiologists

  • 16:20 Popularity of respiratory physiology degree courses

  • 17:09 Challenges in recruitment and retention

  • 17:50 Additional postgraduate training opportunities: Master of Science

  • 20:10 Staff shortages and workloads

  • 21:45 The impact of integrated community care hubs on tertiary care staffing

  • 22:26 Vision for lung function diagnostics in the integrated care hub

  • 27:18 What keeps you engaged?

]]> 1877 Breathwork - Pleural Effusions with Dr Laura Gleeson (Part 2) This week, we speak to Dr. Laura Gleeson again—this time about pleural effusions. Our conversation covers all the pleural effusion basics, plus the nuances of radiology, when to insert a chest drain, and how to monitor it once it’s in place. Chapters: 01:05 – Rapid fire round 04:23 – Pleural effusion intro 05:30 – Symptoms at presentation with pleural effusion 06:40 – Interpreting a white-out on CXR 07:20 – When to do further radiology/imaging 08:35 – CT pre or post chest drain insertion? 10:25 – Light’s criteria – can it always be trusted? 12:00 – What tests to send on your pleural fluid sample 14:15 – Chest drain indications 16:35 – Monitoring your chest drain 21:00 – Flushing the chest drain 22:20 – How much fluid to drain 25:00 – Removing the chest drain 27:10 – Empyema management 30:10 – Fibrinolysis 31:55 – Following up your pleural patients 34:10 – Take-home points Show notes & resources: Light’s criteria – MDCalc calculator | CHEST Clinics article MIST trials – MIST2 – NEJM | MIST3 – ATS Journals Tue, 05 Aug 2025 14:12:00 -0000 full The Podcast Studios This week, we speak to Dr. Laura Gleeson again—this time about pleural effusions. Our conversation covers all the pleural effusion basics, plus the nuances of radiology, when to insert a chest drain, and how to monitor it once it’s in place. Chapters: 01:05 – Rapid fire round 04:23 – Pleural effusion intro 05:30 – Symptoms at presentation with pleural effusion 06:40 – Interpreting a white-out on CXR 07:20 – When to do further radiology/imaging 08:35 – CT pre or post chest drain insertion? 10:25 – Light’s criteria – can it always be trusted? 12:00 – What tests to send on your pleural fluid sample 14:15 – Chest drain indications 16:35 – Monitoring your chest drain 21:00 – Flushing the chest drain 22:20 – How much fluid to drain 25:00 – Removing the chest drain 27:10 – Empyema management 30:10 – Fibrinolysis 31:55 – Following up your pleural patients 34:10 – Take-home points Show notes & resources: Light’s criteria – MDCalc calculator | CHEST Clinics article MIST trials – MIST2 – NEJM | MIST3 – ATS Journals This week, we speak to Dr. Laura Gleeson again—this time about pleural effusions. Our conversation covers all the pleural effusion basics, plus the nuances of radiology, when to insert a chest drain, and how to monitor it once it’s in place.


Chapters:

  • 01:05 – Rapid fire round

  • 04:23 – Pleural effusion intro

  • 05:30 – Symptoms at presentation with pleural effusion

  • 06:40 – Interpreting a white-out on CXR

  • 07:20 – When to do further radiology/imaging

  • 08:35 – CT pre or post chest drain insertion?

  • 10:25 – Light’s criteria – can it always be trusted?

  • 12:00 – What tests to send on your pleural fluid sample

  • 14:15 – Chest drain indications

  • 16:35 – Monitoring your chest drain

  • 21:00 – Flushing the chest drain

  • 22:20 – How much fluid to drain

  • 25:00 – Removing the chest drain

  • 27:10 – Empyema management

  • 30:10 – Fibrinolysis

  • 31:55 – Following up your pleural patients

  • 34:10 – Take-home points

Show notes & resources:

]]> 2172 Inspire: Early consultant years with Dr Laura Gleeson (Part 1) In this episode, we speak with Dr. Laura Gleeson, Respiratory Consultant in St James Hospital, about her journey into respiratory medicine and her diverse specialist interests. She shares valuable insights on preparing for consultant interviews and highlights the importance of networking. We explore the realities of early career life and the transition into the first years as a consultant. Dr. Gleeson also reflects on the challenges of setting up a new clinical service and the key tools that can support success. (Recorded June 2024). Chapters 00:43 Introduction 01:24 Pathway to respiratory and special interest in immunology, TB, and pleural disease 07:00 Networking and preparation ahead of a consultant interview 10:23 The interview for a consultant post 11:00 Being on the consultant interview panel 12:35 The inspo for the ambulatory pleural service 14:00 Career focus and fellowship 16:45 Challenges when developing a new clinical service 18:59 Money talks and other methods of engaging management 22:14 Gaining momentum and the Spark Innovation Fund Show Notes 1. Developing an Ambulatory Pleural Effusion Service https://www.gov.ie/en/department-of-public-expenditure-infrastructure-public-service-reform-and-digitalisation/publications/developing-an-ambulatory-pleural-effusion-service/ 2. Healthcare team of the year award for the St Jame’s Hospital Ambulatory Pleural Effusion Sevice https://x.com/stjamesdublin/status/1926927226848633028 Mon, 21 Jul 2025 12:34:00 -0000 full The Podcast Studios In this episode, we speak with Dr. Laura Gleeson, Respiratory Consultant in St James Hospital, about her journey into respiratory medicine and her diverse specialist interests. She shares valuable insights on preparing for consultant interviews and highlights the importance of networking. We explore the realities of early career life and the transition into the first years as a consultant. Dr. Gleeson also reflects on the challenges of setting up a new clinical service and the key tools that can support success. (Recorded June 2024). Chapters 00:43 Introduction 01:24 Pathway to respiratory and special interest in immunology, TB, and pleural disease 07:00 Networking and preparation ahead of a consultant interview 10:23 The interview for a consultant post 11:00 Being on the consultant interview panel 12:35 The inspo for the ambulatory pleural service 14:00 Career focus and fellowship 16:45 Challenges when developing a new clinical service 18:59 Money talks and other methods of engaging management 22:14 Gaining momentum and the Spark Innovation Fund Show Notes 1. Developing an Ambulatory Pleural Effusion Service https://www.gov.ie/en/department-of-public-expenditure-infrastructure-public-service-reform-and-digitalisation/publications/developing-an-ambulatory-pleural-effusion-service/ 2. Healthcare team of the year award for the St Jame’s Hospital Ambulatory Pleural Effusion Sevice https://x.com/stjamesdublin/status/1926927226848633028 In this episode, we speak with Dr. Laura Gleeson, Respiratory Consultant in St James Hospital, about her journey into respiratory medicine and her diverse specialist interests. She shares valuable insights on preparing for consultant interviews and highlights the importance of networking. We explore the realities of early career life and the transition into the first years as a consultant. Dr. Gleeson also reflects on the challenges of setting up a new clinical service and the key tools that can support success. (Recorded June 2024).


Chapters

00:43 Introduction

01:24 Pathway to respiratory and special interest in immunology, TB, and pleural disease

07:00 Networking and preparation ahead of a consultant interview

10:23 The interview for a consultant post

11:00 Being on the consultant interview panel

12:35 The inspo for the ambulatory pleural service

14:00 Career focus and fellowship

16:45 Challenges when developing a new clinical service

18:59 Money talks and other methods of engaging management

22:14 Gaining momentum and the Spark Innovation Fund


Show Notes

1. Developing an Ambulatory Pleural Effusion Service

https://www.gov.ie/en/department-of-public-expenditure-infrastructure-public-service-reform-and-digitalisation/publications/developing-an-ambulatory-pleural-effusion-service/


2. Healthcare team of the year award for the St Jame’s Hospital Ambulatory Pleural Effusion Sevice

https://x.com/stjamesdublin/status/1926927226848633028

]]> 1441 Breathwork: Pulmonary Hypertension with Professor Sean Gaine (Part 2) This week, we’re joined by Professor Seán Gaine, Ireland’s foremost expert in pulmonary hypertension. In this insightful episode, he shares his expert perspective on the diagnosis, classification, and clinical presentation of the condition, as well as the latest advances in treatment. A must-listen for all healthcare professionals, Professor Gaine also discusses when to suspect pulmonary hypertension and highlights the nuances in the management of patients with pulmonary hypertension. Don’t miss this opportunity to learn from a global leader in the field. Chapters 0:52 Rapid fire round on pulmonary hypertension 01:42 Definition of pulmonary hypertension 02:08 Signs and symptoms of pulmonary hypertension 02:56 Five groups of pulmonary hypertension 03:33 Group 1 pulmonary hypertension: Pulmonary arterial hypertension 04:34 Group 2 pulmonary hypertension: Left heart disease 05:23 Group 3 pulmonary hypertension: Chronic lung disease/hypoxia 05:58 Group 4 pulmonary hypertension: Pulmonary vascular obstruction 06:30 Group 5 pulmonary hypertension: Miscellaneous 07:25 Referral to the national pulmonary hypertension centre: right heart catheterisation 09:37 Work up in the pulmonary hypertension clinic 11:06 Risk stratification in pulmonary hypertension 12:06 Diagnostic criteria pulmonary hypertension Dynamic testing right heart catheterisation: Cardiopulmonary exercise testing Reliability of right heart catheterisation Treatment algorithm in pulmonary arterial hypertension Tripple therapy for high risk patients Double combination therapy for non-high risk patients Fourth treatment pathway, Quadruple therapy?: Sotatercept - an activin scavenger Treatment options for groups 4 pulmonary hypertension: Balloon pulmonary angioplasty Treatment options for groups 2, 3 and 5 Side effects of triple therapy Lung transplant in pulmonary hypertension: Double or single lung transplant Pitfalls in the acute management of patients with pulmonary hypertension Interpretation of the B Natriuretic Peptide level Medications contraindicated pulmonary hypertensions Outcomes in pulmonary hypertension Take home message on pulmonary hypertension Show Notes - https://lumen5.com/user/edofficer/sotatercept-emergin-d5jg6/ - Irish Thoracic Society Flashcard Pulmonary Hypertension https://irishthoracicsociety.com/wp-content/uploads/2021/06/5.-Pulmonary-Hypertension.pdf - Benza RL, Kanwar MK, Raina A, et al. Development and validation of an abridged version of the REVEAL 2.0 risk score calculator, REVEAL Lite 2, for use in patients with pulmonary arterial hypertension. Chest 2021; 159: 337–346. - Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. European Respiratory Journal. 2022:2200879. DOI: https://doi.org/10.1183/13993003.00879-2022 - Chin KM, Gaine SP, Gerges C, Jing Z-C, Mathai SC, Tamura Y, et al. Treatment algorithm for pulmonary arterial hypertension. European Respiratory Journal. 2024;64(4):2401325. DOI: https://doi.org/10.1183/13993003.01325-2024 - Hoeper, M.M., Badesch, D.B., Ghofrani, H.A., Gibbs, J.S.R., GombergMaitland, M., McLaughlin, V.V. et al. (2023) ‘Phase 3 trial of sotatercept for treatment of pulmonary arterial hypertension’, New England Journal of Medicine, 388(17), pp. 1478–1490. Available at: https://doi.org/10.1056/NEJMoa2213558 - Humbert M, McLaughlin VV, Badesch DB, Ghofrani HA, Gibbs JSR, Gomberg-Maitland M, et al. Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for Death. N Engl J Med. 2025;392(20):1987-2000. DOI: 10.1056/NEJMoa2415160 Mon, 07 Jul 2025 11:43:00 -0000 full The Podcast Studios This week, we’re joined by Professor Seán Gaine, Ireland’s foremost expert in pulmonary hypertension. In this insightful episode, he shares his expert perspective on the diagnosis, classification, and clinical presentation of the condition, as well as the latest advances in treatment. A must-listen for all healthcare professionals, Professor Gaine also discusses when to suspect pulmonary hypertension and highlights the nuances in the management of patients with pulmonary hypertension. Don’t miss this opportunity to learn from a global leader in the field. Chapters 0:52 Rapid fire round on pulmonary hypertension 01:42 Definition of pulmonary hypertension 02:08 Signs and symptoms of pulmonary hypertension 02:56 Five groups of pulmonary hypertension 03:33 Group 1 pulmonary hypertension: Pulmonary arterial hypertension 04:34 Group 2 pulmonary hypertension: Left heart disease 05:23 Group 3 pulmonary hypertension: Chronic lung disease/hypoxia 05:58 Group 4 pulmonary hypertension: Pulmonary vascular obstruction 06:30 Group 5 pulmonary hypertension: Miscellaneous 07:25 Referral to the national pulmonary hypertension centre: right heart catheterisation 09:37 Work up in the pulmonary hypertension clinic 11:06 Risk stratification in pulmonary hypertension 12:06 Diagnostic criteria pulmonary hypertension Dynamic testing right heart catheterisation: Cardiopulmonary exercise testing Reliability of right heart catheterisation Treatment algorithm in pulmonary arterial hypertension Tripple therapy for high risk patients Double combination therapy for non-high risk patients Fourth treatment pathway, Quadruple therapy?: Sotatercept - an activin scavenger Treatment options for groups 4 pulmonary hypertension: Balloon pulmonary angioplasty Treatment options for groups 2, 3 and 5 Side effects of triple therapy Lung transplant in pulmonary hypertension: Double or single lung transplant Pitfalls in the acute management of patients with pulmonary hypertension Interpretation of the B Natriuretic Peptide level Medications contraindicated pulmonary hypertensions Outcomes in pulmonary hypertension Take home message on pulmonary hypertension Show Notes - https://lumen5.com/user/edofficer/sotatercept-emergin-d5jg6/ - Irish Thoracic Society Flashcard Pulmonary Hypertension https://irishthoracicsociety.com/wp-content/uploads/2021/06/5.-Pulmonary-Hypertension.pdf - Benza RL, Kanwar MK, Raina A, et al. Development and validation of an abridged version of the REVEAL 2.0 risk score calculator, REVEAL Lite 2, for use in patients with pulmonary arterial hypertension. Chest 2021; 159: 337–346. - Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. European Respiratory Journal. 2022:2200879. DOI: https://doi.org/10.1183/13993003.00879-2022 - Chin KM, Gaine SP, Gerges C, Jing Z-C, Mathai SC, Tamura Y, et al. Treatment algorithm for pulmonary arterial hypertension. European Respiratory Journal. 2024;64(4):2401325. DOI: https://doi.org/10.1183/13993003.01325-2024 - Hoeper, M.M., Badesch, D.B., Ghofrani, H.A., Gibbs, J.S.R., GombergMaitland, M., McLaughlin, V.V. et al. (2023) ‘Phase 3 trial of sotatercept for treatment of pulmonary arterial hypertension’, New England Journal of Medicine, 388(17), pp. 1478–1490. Available at: https://doi.org/10.1056/NEJMoa2213558 - Humbert M, McLaughlin VV, Badesch DB, Ghofrani HA, Gibbs JSR, Gomberg-Maitland M, et al. Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for Death. N Engl J Med. 2025;392(20):1987-2000. DOI: 10.1056/NEJMoa2415160 This week, we’re joined by Professor Seán Gaine, Ireland’s foremost expert in pulmonary hypertension. In this insightful episode, he shares his expert perspective on the diagnosis, classification, and clinical presentation of the condition, as well as the latest advances in treatment.

A must-listen for all healthcare professionals, Professor Gaine also discusses when to suspect pulmonary hypertension and highlights the nuances in the management of patients with pulmonary hypertension. Don’t miss this opportunity to learn from a global leader in the field.


Chapters

0:52 Rapid fire round on pulmonary hypertension

01:42 Definition of pulmonary hypertension

02:08 Signs and symptoms of pulmonary hypertension

02:56 Five groups of pulmonary hypertension

03:33 Group 1 pulmonary hypertension: Pulmonary arterial hypertension

04:34 Group 2 pulmonary hypertension: Left heart disease

05:23 Group 3 pulmonary hypertension: Chronic lung disease/hypoxia

05:58 Group 4 pulmonary hypertension: Pulmonary vascular obstruction

06:30 Group 5 pulmonary hypertension: Miscellaneous

07:25 Referral to the national pulmonary hypertension centre: right heart catheterisation

09:37 Work up in the pulmonary hypertension clinic

11:06 Risk stratification in pulmonary hypertension

12:06 Diagnostic criteria pulmonary hypertension

Dynamic testing right heart catheterisation: Cardiopulmonary exercise testing Reliability of right heart catheterisation


Treatment algorithm in pulmonary arterial hypertension Tripple therapy for high risk patients


Double combination therapy for non-high risk patients


Fourth treatment pathway, Quadruple therapy?: Sotatercept - an activin

scavenger Treatment options for groups 4 pulmonary hypertension: Balloon pulmonary angioplasty


Treatment options for groups 2, 3 and 5


Side effects of triple therapy


Lung transplant in pulmonary hypertension: Double or single lung transplant


Pitfalls in the acute management of patients with pulmonary hypertension


Interpretation of the B Natriuretic Peptide level


Medications contraindicated pulmonary hypertensions


Outcomes in pulmonary hypertension


Take home message on pulmonary hypertension


Show Notes

- https://lumen5.com/user/edofficer/sotatercept-emergin-d5jg6/

- Irish Thoracic Society Flashcard Pulmonary Hypertension

https://irishthoracicsociety.com/wp-content/uploads/2021/06/5.-Pulmonary-Hypertension.pdf

- Benza RL, Kanwar MK, Raina A, et al. Development and validation of an abridged version of the REVEAL 2.0 risk score calculator, REVEAL Lite 2, for use in patients with pulmonary arterial hypertension. Chest 2021; 159: 337–346.


- Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. European Respiratory Journal. 2022:2200879.

DOI: https://doi.org/10.1183/13993003.00879-2022


- Chin KM, Gaine SP, Gerges C, Jing Z-C, Mathai SC, Tamura Y, et al. Treatment algorithm for pulmonary arterial hypertension. European Respiratory Journal. 2024;64(4):2401325. DOI: https://doi.org/10.1183/13993003.01325-2024


- Hoeper, M.M., Badesch, D.B., Ghofrani, H.A., Gibbs, J.S.R., GombergMaitland, M., McLaughlin, V.V. et al. (2023) ‘Phase 3 trial of sotatercept for treatment of pulmonary arterial hypertension’, New England Journal of Medicine, 388(17), pp. 1478–1490. Available at:

https://doi.org/10.1056/NEJMoa2213558


- Humbert M, McLaughlin VV, Badesch DB, Ghofrani HA, Gibbs JSR, Gomberg-Maitland M, et al. Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for Death. N Engl J Med. 2025;392(20):1987-2000. DOI: 10.1056/NEJMoa2415160

]]> 2386 Inspire: Professor Sean Gaine on setting up pulmonary hypertension centres and his role as chief medical officer for the Irish Olympic Teams (Part 1) This week, we speak with Professor Sean Gaine about his distinguished career—from his work establishing the Pulmonary Hypertension Program at Johns Hopkins Hospital and later founding Ireland’s National Pulmonary Hypertension Centre as well as serving as Chief Medical Officer for the Irish Olympic Teams. He shares thoughtful insights and experiences from a remarkable career with more stories than could ever be squeezed into one episode. Chapters 01:56 Residency in the Johns Hopkins Hospital 03:37 Introduction to Pulmonary Hypertension 05:56 Establishing the Pulmonary Hypertension Unit in the Johns Hopkins Hospital 14:01 Establishing the National Pulmonary Hypertension Programme in Ireland 15:51 Essential role of clinical nurse specialists 18:01 Chief Medical Officer Irish Olympic Teams 25:46 Sustaining enthusiasm in a career in medicine Show Notes 1. Rubin, Lewis J., and Stuart Rich, editors. Primary Pulmonary Hypertension. Marcel Dekker, 1996. Lung Biology in Health and Disease. 2. https://www.irishtimes.com/sport/athletics/2024/05/18/jamie-costin-was-27-in-the-shape-of-his-life-ready-for-the-olympics-then-he-got-hit-by-a-truck/ 3. https://lumen5.com/user/edofficer/sean-gaine-olympic-cq0g0/ Mon, 23 Jun 2025 09:23:00 -0000 full The Podcast Studios This week, we speak with Professor Sean Gaine about his distinguished career—from his work establishing the Pulmonary Hypertension Program at Johns Hopkins Hospital and later founding Ireland’s National Pulmonary Hypertension Centre as well as serving as Chief Medical Officer for the Irish Olympic Teams. He shares thoughtful insights and experiences from a remarkable career with more stories than could ever be squeezed into one episode. Chapters 01:56 Residency in the Johns Hopkins Hospital 03:37 Introduction to Pulmonary Hypertension 05:56 Establishing the Pulmonary Hypertension Unit in the Johns Hopkins Hospital 14:01 Establishing the National Pulmonary Hypertension Programme in Ireland 15:51 Essential role of clinical nurse specialists 18:01 Chief Medical Officer Irish Olympic Teams 25:46 Sustaining enthusiasm in a career in medicine Show Notes 1. Rubin, Lewis J., and Stuart Rich, editors. Primary Pulmonary Hypertension. Marcel Dekker, 1996. Lung Biology in Health and Disease. 2. https://www.irishtimes.com/sport/athletics/2024/05/18/jamie-costin-was-27-in-the-shape-of-his-life-ready-for-the-olympics-then-he-got-hit-by-a-truck/ 3. https://lumen5.com/user/edofficer/sean-gaine-olympic-cq0g0/ This week, we speak with Professor Sean Gaine about his distinguished career—from his work establishing the Pulmonary Hypertension Program at Johns Hopkins Hospital and later founding Ireland’s National Pulmonary Hypertension Centre as well as serving as Chief Medical Officer for the Irish Olympic Teams. He shares thoughtful insights and experiences from a remarkable career with more stories than could ever be squeezed into one episode.


Chapters

01:56 Residency in the Johns Hopkins Hospital

03:37 Introduction to Pulmonary Hypertension

05:56 Establishing the Pulmonary Hypertension Unit in the Johns Hopkins Hospital

14:01 Establishing the National Pulmonary Hypertension Programme in Ireland

15:51 Essential role of clinical nurse specialists

18:01 Chief Medical Officer Irish Olympic Teams

25:46 Sustaining enthusiasm in a career in medicine


Show Notes

1. Rubin, Lewis J., and Stuart Rich, editors. Primary Pulmonary Hypertension. Marcel Dekker, 1996. Lung Biology in Health and Disease.

2. https://www.irishtimes.com/sport/athletics/2024/05/18/jamie-costin-was-27-in-the-shape-of-his-life-ready-for-the-olympics-then-he-got-hit-by-a-truck/

3. https://lumen5.com/user/edofficer/sean-gaine-olympic-cq0g0/

]]> 1747 Breathwork: Asthma Biologic Therapies with Mr. Stephen Shelly (Part 2) Description This week we speak to Mr Stephen Shelly again about the exciting but sometimes mysterious world of asthma biologics. We speak about the different biologics, going about getting approval to start an asthma biologic, training, and treatment response. We speak about the potential impact that asthma biologics are going to have on the future of asthma (and hopefully COPD!), the cost benefit analysis and the limitations of these new wonder drugs. Chapters 0.42min Intro to Biologics 1.00min Rapid fire round 1.52min Severe asthma & biologic eligibility 3.50min Available biologics 6.50min Which biologic? 7.30min Journey to asthma biologic 13.55min Asthma biologic administration 15.30min Monitoring while on asthma biologic 16.40min Training for asthma biologic admin at home 18.50min Assessing treatment response 21:10min Patient expectations 24:50min Are inhalers still needed? 26:12min Pitfalls in treatment with asthma biologics 28:54min Cost-benefit analysis 31.30min Take-home points Show notes Dupilumab https://www.nejm.org/doi/10.1056/NEJMoa1804092 Mepolizumab https://www.nejm.org/doi/10.1056/NEJMoa1403290 Omalizumab https://www.jacionline.org/article/S0091-6749(01)65945-1/fulltext Benralizumab https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)31322-8/abstractTezepelumab https://doi.org/10.1164/rccm.202210-2005OC Difficult to treat asthma (GINA) https://ginasthma.org/wp-content/uploads/2024/11/GINA-Severe-Asthma-Guide-2024-WEB-WMS.pdf Asthma compliance programmes Ireland https://www.rcsi.com/dublin/research-and-innovation/innovation/investors-entrepreneurs-and-spin-outs/phyxiom Mon, 26 May 2025 12:55:00 -0000 full The Podcast Studios Description This week we speak to Mr Stephen Shelly again about the exciting but sometimes mysterious world of asthma biologics. We speak about the different biologics, going about getting approval to start an asthma biologic, training, and treatment response. We speak about the potential impact that asthma biologics are going to have on the future of asthma (and hopefully COPD!), the cost benefit analysis and the limitations of these new wonder drugs. Chapters 0.42min Intro to Biologics 1.00min Rapid fire round 1.52min Severe asthma & biologic eligibility 3.50min Available biologics 6.50min Which biologic? 7.30min Journey to asthma biologic 13.55min Asthma biologic administration 15.30min Monitoring while on asthma biologic 16.40min Training for asthma biologic admin at home 18.50min Assessing treatment response 21:10min Patient expectations 24:50min Are inhalers still needed? 26:12min Pitfalls in treatment with asthma biologics 28:54min Cost-benefit analysis 31.30min Take-home points Show notes Dupilumab https://www.nejm.org/doi/10.1056/NEJMoa1804092 Mepolizumab https://www.nejm.org/doi/10.1056/NEJMoa1403290 Omalizumab https://www.jacionline.org/article/S0091-6749(01)65945-1/fulltext Benralizumab https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)31322-8/abstractTezepelumab https://doi.org/10.1164/rccm.202210-2005OC Difficult to treat asthma (GINA) https://ginasthma.org/wp-content/uploads/2024/11/GINA-Severe-Asthma-Guide-2024-WEB-WMS.pdf Asthma compliance programmes Ireland https://www.rcsi.com/dublin/research-and-innovation/innovation/investors-entrepreneurs-and-spin-outs/phyxiom Description

This week we speak to Mr Stephen Shelly again about the exciting but sometimes mysterious world of asthma biologics. We speak about the different biologics, going about getting approval to start an asthma biologic, training, and treatment response.

We speak about the potential impact that asthma biologics are going to have on the future of asthma (and hopefully COPD!), the cost benefit analysis and the limitations of these new wonder drugs.

Chapters

0.42min Intro to Biologics

1.00min Rapid fire round

1.52min Severe asthma & biologic eligibility

3.50min Available biologics

6.50min Which biologic?

7.30min Journey to asthma biologic

13.55min Asthma biologic administration

15.30min Monitoring while on asthma biologic

16.40min Training for asthma biologic admin at home

18.50min Assessing treatment response

21:10min Patient expectations

24:50min Are inhalers still needed?

26:12min Pitfalls in treatment with asthma biologics

28:54min Cost-benefit analysis

31.30min Take-home points

Show notes

Dupilumab https://www.nejm.org/doi/10.1056/NEJMoa1804092

Mepolizumab https://www.nejm.org/doi/10.1056/NEJMoa1403290

Omalizumab https://www.jacionline.org/article/S0091-6749(01)65945-1/fulltext

Benralizumab https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)31322-8/abstractTezepelumab

https://doi.org/10.1164/rccm.202210-2005OC

Difficult to treat asthma (GINA) https://ginasthma.org/wp-content/uploads/2024/11/GINA-Severe-Asthma-Guide-2024-WEB-WMS.pdf

Asthma compliance programmes Ireland https://www.rcsi.com/dublin/research-and-innovation/innovation/investors-entrepreneurs-and-spin-outs/phyxiom

]]> 1987 Inspire: Mr Stephen Shelly on pursuing a career as an advanced nurse practitioner (part 1) In this episode we speak to Mr Stephen Shelly, Advanced Nurse Practitioner in Respiratory Medicine in St James’ University hospital. Stephen completed his nursing, CNS and ANP training in SJH with a special interest in airways disease. In the ANP role he has introduced new pathways for direct GP referrals to his clinic and enhanced the early discharge programme for patients attending the emergency department with COPD. We discuss his career to date, the process for pursuing a career as an ANP, challenges along the way and tips for others with an interest in becoming an ANP. Chapters 00:45 Intro to Mr Stephen Shelly 02:05 Why he pursued a career in Respiratory medicine 04:30 Stephen’ early nursing career 05:40 Working as a clinical nurse specialist (CNS) 06:10 Overview of ANP training process 07:40 ANP Dragon’s Den 09:10 Different pathways to becoming an ANP 11:50 Future of ANPs in Ireland 14:00 Tips in advance of applying for an ANP role 19:30 Transition from CNS to ANP 22:10 Liaising with NCHDs/ junior doctors 24:30 Biggest challenges to date 28:30 Top tips for people starting out their nursing career 29:35 Wrap up Show notes ANP registration Ireland https://www.nmbi.ie/Registration/Add-New-Division/Advanced-Practitioners/Registering-as-ANP-AMP CNS training Ireland https://healthservice.hse.ie/about-us/onmsd/advanced-and-specialist-practice/specialist-practice.html Post graduate nursing courses Ireland https://www.nmbi.ie/Education/post-registration-courses Tue, 13 May 2025 12:24:00 -0000 full The Podcast Studios In this episode we speak to Mr Stephen Shelly, Advanced Nurse Practitioner in Respiratory Medicine in St James’ University hospital. Stephen completed his nursing, CNS and ANP training in SJH with a special interest in airways disease. In the ANP role he has introduced new pathways for direct GP referrals to his clinic and enhanced the early discharge programme for patients attending the emergency department with COPD. We discuss his career to date, the process for pursuing a career as an ANP, challenges along the way and tips for others with an interest in becoming an ANP. Chapters 00:45 Intro to Mr Stephen Shelly 02:05 Why he pursued a career in Respiratory medicine 04:30 Stephen’ early nursing career 05:40 Working as a clinical nurse specialist (CNS) 06:10 Overview of ANP training process 07:40 ANP Dragon’s Den 09:10 Different pathways to becoming an ANP 11:50 Future of ANPs in Ireland 14:00 Tips in advance of applying for an ANP role 19:30 Transition from CNS to ANP 22:10 Liaising with NCHDs/ junior doctors 24:30 Biggest challenges to date 28:30 Top tips for people starting out their nursing career 29:35 Wrap up Show notes ANP registration Ireland https://www.nmbi.ie/Registration/Add-New-Division/Advanced-Practitioners/Registering-as-ANP-AMP CNS training Ireland https://healthservice.hse.ie/about-us/onmsd/advanced-and-specialist-practice/specialist-practice.html Post graduate nursing courses Ireland https://www.nmbi.ie/Education/post-registration-courses In this episode we speak to Mr Stephen Shelly, Advanced Nurse Practitioner in Respiratory Medicine in St James’ University hospital.

Stephen completed his nursing, CNS and ANP training in SJH with a special interest in airways disease. In the ANP role he has introduced new pathways for direct GP referrals to his clinic and enhanced the early discharge programme for patients attending the emergency department with COPD.

We discuss his career to date, the process for pursuing a career as an ANP, challenges along the way and tips for others with an interest in becoming an ANP.


Chapters

00:45 Intro to Mr Stephen Shelly

02:05 Why he pursued a career in Respiratory medicine

04:30 Stephen’ early nursing career

05:40 Working as a clinical nurse specialist (CNS)

06:10 Overview of ANP training process

07:40 ANP Dragon’s Den

09:10 Different pathways to becoming an ANP

11:50 Future of ANPs in Ireland

14:00 Tips in advance of applying for an ANP role

19:30 Transition from CNS to ANP

22:10 Liaising with NCHDs/ junior doctors

24:30 Biggest challenges to date

28:30 Top tips for people starting out their nursing career

29:35 Wrap up


Show notes

ANP registration Ireland https://www.nmbi.ie/Registration/Add-New-Division/Advanced-Practitioners/Registering-as-ANP-AMP

CNS training Ireland https://healthservice.hse.ie/about-us/onmsd/advanced-and-specialist-practice/specialist-practice.html

Post graduate nursing courses Ireland https://www.nmbi.ie/Education/post-registration-courses

]]> 1814 Breathwork: Sarcoidosis with Professor Anthony O'Regan (Part 2) In this episode, we delve into sarcoidosis with Professor Anthony O'Regan. We discuss the nuances of diagnosing sarcoidosis and revisit the pathophysiology of the condition. This episodes details the importance of follow up care and provides insights into how to tease out differentials. Furthermore, we address how to determine which patients should be treated, along with choice of treatments and duration. 00:15 Rapid fire round: sarcoidosis 00:45 Pathophysiology of sarcoidosis 05:30 Multisystem involvement in sarcoidosis 07:15 Granulomatous disease 09:00 Referral to respiratory clinic (Symptoms/Differentials/Family history/Travel) 10:30 Initial investigations 10:45 Coming to a diagnosis of sarcoidosis 14:05 The role of biopsy in diagnosis of sarcoidosis 15:50 Teasing out the differentials in follow up 17:35 When to treat in sarcoidosis 19:25 Duration of treatment 19:50 Relapse of disease 21:00 Starting dose of steroids 22:00 Disease modifying therapy 23:30 Antifibrotics 24:25 Follow up in sarcoidosis 25:01 The future of sarcoidosis Show Notes: - Judson MA, Baughman RP, Teirstein AS, Terrin ML, Yeager H Jr. Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. ACCESS Research Group. A Case Control Etiologic Study of Sarcoidosis. Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG. 1999 Mar;16(1):75-86. PMID: 10207945. - 40 consecutive patients in Ireland 20% end up on steroids - John Gibson study on steroids RCT Gibson GJ, Prescott RJ, Muers MF, Middleton WG, Mitchell DN, Connolly CK. "British Thoracic Society Sarcoidosis study: effects of long-term corticosteroid treatment." Thorax. 1996;51(3):238-247. DOI: 10.1136/thx.51.3.238 - Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial Wells, Athol UAbe, S. et al. The Lancet Respiratory Medicine, Volume 8, Issue 5, 453 – 460 - ITS Flashcard Sarcoidosis https://irishthoracicsociety.com/wp-content/uploads/2022/02/15.-Sarcoidosis-30.11.21.pdf Wed, 30 Apr 2025 06:00:00 -0000 full The Podcast Studios In this episode, we delve into sarcoidosis with Professor Anthony O'Regan. We discuss the nuances of diagnosing sarcoidosis and revisit the pathophysiology of the condition. This episodes details the importance of follow up care and provides insights into how to tease out differentials. Furthermore, we address how to determine which patients should be treated, along with choice of treatments and duration. 00:15 Rapid fire round: sarcoidosis 00:45 Pathophysiology of sarcoidosis 05:30 Multisystem involvement in sarcoidosis 07:15 Granulomatous disease 09:00 Referral to respiratory clinic (Symptoms/Differentials/Family history/Travel) 10:30 Initial investigations 10:45 Coming to a diagnosis of sarcoidosis 14:05 The role of biopsy in diagnosis of sarcoidosis 15:50 Teasing out the differentials in follow up 17:35 When to treat in sarcoidosis 19:25 Duration of treatment 19:50 Relapse of disease 21:00 Starting dose of steroids 22:00 Disease modifying therapy 23:30 Antifibrotics 24:25 Follow up in sarcoidosis 25:01 The future of sarcoidosis Show Notes: - Judson MA, Baughman RP, Teirstein AS, Terrin ML, Yeager H Jr. Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. ACCESS Research Group. A Case Control Etiologic Study of Sarcoidosis. Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG. 1999 Mar;16(1):75-86. PMID: 10207945. - 40 consecutive patients in Ireland 20% end up on steroids - John Gibson study on steroids RCT Gibson GJ, Prescott RJ, Muers MF, Middleton WG, Mitchell DN, Connolly CK. "British Thoracic Society Sarcoidosis study: effects of long-term corticosteroid treatment." Thorax. 1996;51(3):238-247. DOI: 10.1136/thx.51.3.238 - Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial Wells, Athol UAbe, S. et al. The Lancet Respiratory Medicine, Volume 8, Issue 5, 453 – 460 - ITS Flashcard Sarcoidosis https://irishthoracicsociety.com/wp-content/uploads/2022/02/15.-Sarcoidosis-30.11.21.pdf In this episode, we delve into sarcoidosis with Professor Anthony O'Regan. We discuss the nuances of diagnosing sarcoidosis and revisit the pathophysiology of the condition. This episodes details the importance of follow up care and provides insights into how to tease out differentials. Furthermore, we address how to determine which patients should be treated, along with choice of treatments and duration.


00:15 Rapid fire round: sarcoidosis

00:45 Pathophysiology of sarcoidosis

05:30 Multisystem involvement in sarcoidosis

07:15 Granulomatous disease

09:00 Referral to respiratory clinic (Symptoms/Differentials/Family history/Travel)

10:30 Initial investigations

10:45 Coming to a diagnosis of sarcoidosis

14:05 The role of biopsy in diagnosis of sarcoidosis

15:50 Teasing out the differentials in follow up

17:35 When to treat in sarcoidosis

19:25 Duration of treatment

19:50 Relapse of disease

21:00 Starting dose of steroids

22:00 Disease modifying therapy

23:30 Antifibrotics

24:25 Follow up in sarcoidosis

25:01 The future of sarcoidosis


Show Notes:

- Judson MA, Baughman RP, Teirstein AS, Terrin ML, Yeager H Jr. Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. ACCESS Research Group. A Case Control Etiologic Study of Sarcoidosis. Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG. 1999 Mar;16(1):75-86. PMID: 10207945.


- 40 consecutive patients in Ireland

20% end up on steroids


- John Gibson study on steroids RCT

Gibson GJ, Prescott RJ, Muers MF, Middleton WG, Mitchell DN, Connolly CK. "British Thoracic Society Sarcoidosis study: effects of long-term corticosteroid treatment." Thorax. 1996;51(3):238-247. DOI: 10.1136/thx.51.3.238


- Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial Wells, Athol UAbe, S. et al. The Lancet Respiratory Medicine, Volume 8, Issue 5, 453 – 460


- ITS Flashcard Sarcoidosis https://irishthoracicsociety.com/wp-content/uploads/2022/02/15.-Sarcoidosis-30.11.21.pdf

]]> 1640 Inspire: Dr Anthony O’Regan on improving junior doctor training and leadership roles in the HSE (Part 1) In this episode we speak to Dr Anthony O’Regan, Consultant Respiratory Physician working in Galway University hospital. Anthony completed his early training in the US and since coming back has worked with the Irish Thoracic Society, Royal College of Physicians Ireland and National Doctors Training and Planning to try and improve working conditions and training for junior doctors in Ireland. We discuss the progress made to date, ongoing projects and healthcare planning for the future changes we will see in our population. Chapters 0.45 Intro to Dr Anthony O’Regan 1.50 Why he pursued Respiratory mediicne 3.20 ITS presidency 7.25 ILD registries 8.50 RCPI and working conditions 14.00 Medical training in Ireland 18.45 Exit exams 20.50 Upcoming changes being introduced by NDTP 26.50 Projections for future workforce 31.20 Advice for upcoming trainees Show notes NDTP website (HSE) https://www.hse.ie/eng/staff/leadership-education-development/met/ All information on becoming a member, upcoming events and how to get involved in the RCPI https://www.rcpi.ie/ ITS website https://irishthoracicsociety.com/ Population changes and impacts on healthcare https://doi.org/10.1038/s41514-024-00148-2 Mon, 14 Apr 2025 03:00:00 -0000 Inspire: Dr Anthony O’Regan on improving junior doctor training and leadership roles in the HSE (Part 1) full The Podcast Studios In this episode we speak to Dr Anthony O’Regan, Consultant Respiratory Physician working in Galway University hospital. Anthony completed his early training in the US and since coming back has worked with the Irish Thoracic Society, Royal College of Physicians Ireland and National Doctors Training and Planning to try and improve working conditions and training for junior doctors in Ireland. We discuss the progress made to date, ongoing projects and healthcare planning for the future changes we will see in our population. Chapters 0.45 Intro to Dr Anthony O’Regan 1.50 Why he pursued Respiratory mediicne 3.20 ITS presidency 7.25 ILD registries 8.50 RCPI and working conditions 14.00 Medical training in Ireland 18.45 Exit exams 20.50 Upcoming changes being introduced by NDTP 26.50 Projections for future workforce 31.20 Advice for upcoming trainees Show notes NDTP website (HSE) https://www.hse.ie/eng/staff/leadership-education-development/met/ All information on becoming a member, upcoming events and how to get involved in the RCPI https://www.rcpi.ie/ ITS website https://irishthoracicsociety.com/ Population changes and impacts on healthcare https://doi.org/10.1038/s41514-024-00148-2 In this episode we speak to Dr Anthony O’Regan, Consultant Respiratory Physician working

in Galway University hospital. Anthony completed his early training in the US and since

coming back has worked with the Irish Thoracic Society, Royal College of Physicians Ireland

and National Doctors Training and Planning to try and improve working conditions and

training for junior doctors in Ireland. We discuss the progress made to date, ongoing projects

and healthcare planning for the future changes we will see in our population.


Chapters

0.45 Intro to Dr Anthony O’Regan

1.50 Why he pursued Respiratory mediicne

3.20 ITS presidency

7.25 ILD registries

8.50 RCPI and working conditions

14.00 Medical training in Ireland

18.45 Exit exams

20.50 Upcoming changes being introduced by NDTP

26.50 Projections for future workforce

31.20 Advice for upcoming trainees


Show notes


NDTP website (HSE) https://www.hse.ie/eng/staff/leadership-education-development/met/

All information on becoming a member, upcoming events and how to get involved in the

RCPI https://www.rcpi.ie/

ITS website https://irishthoracicsociety.com/

Population changes and impacts on healthcare https://doi.org/10.1038/s41514-024-00148-2

]]> 2050 Breathwork: All things IPF; Part 2 with Nazia Chaudhuri This week we speak with Nazia again, this time about idiopathic pulmonary fibrosis or IPF for short. Nazia is a leading world expert in the diagnosis and management of IPF and in this episode she shares that expertise with us. Chapters 00:57 - Rapid fire round 01:35 - Introduction to ILD 03:20 - Definition of IPF 04:15 - What to include in your IPF referrals 06:40 - IPF workup 11:55 - Genetics in IPF 14:50 - Management of IPF 20:28 - Acute exacerbation of IPF (AE-IPF) 22:20 - Follow-up and surveillance of IPF patients 26:00 - Prognostication in IPF 27:40 - Encouraging clinical breakthroughs 29:05 - Key take home messages 31:00 - Wrap up Links IPF clinical practice update 2022 ATS/ERS/JRS/ALAT https://doi.org/10.1164/rccm.202202-0399ST Role of MDT in diagnosis of IPF https://doi.org/10.1513/AnnalsATS.202108-979ED Current and future treatments in IPF https://doi.org/10.1007/s40265-023-01950-0 Mon, 31 Mar 2025 05:00:00 -0000 Breathwork: All things IPF; Part 2 with Nazia Chaudhri full The Podcast Studios This week we speak with Nazia again, this time about idiopathic pulmonary fibrosis or IPF for short. Nazia is a leading world expert in the diagnosis and management of IPF and in this episode she shares that expertise with us. Chapters 00:57 - Rapid fire round 01:35 - Introduction to ILD 03:20 - Definition of IPF 04:15 - What to include in your IPF referrals 06:40 - IPF workup 11:55 - Genetics in IPF 14:50 - Management of IPF 20:28 - Acute exacerbation of IPF (AE-IPF) 22:20 - Follow-up and surveillance of IPF patients 26:00 - Prognostication in IPF 27:40 - Encouraging clinical breakthroughs 29:05 - Key take home messages 31:00 - Wrap up Links IPF clinical practice update 2022 ATS/ERS/JRS/ALAT https://doi.org/10.1164/rccm.202202-0399ST Role of MDT in diagnosis of IPF https://doi.org/10.1513/AnnalsATS.202108-979ED Current and future treatments in IPF https://doi.org/10.1007/s40265-023-01950-0 This week we speak with Nazia again, this time about idiopathic pulmonary fibrosis or IPF for short. Nazia is a leading world expert in the diagnosis and management of IPF and in this episode she shares that expertise with us.


Chapters

00:57 - Rapid fire round

01:35 - Introduction to ILD

03:20 - Definition of IPF

04:15 - What to include in your IPF referrals

06:40 - IPF workup

11:55 - Genetics in IPF

14:50 - Management of IPF

20:28 - Acute exacerbation of IPF (AE-IPF)

22:20 - Follow-up and surveillance of IPF patients

26:00 - Prognostication in IPF

27:40 - Encouraging clinical breakthroughs

29:05 - Key take home messages

31:00 - Wrap up


Links

IPF clinical practice update 2022 ATS/ERS/JRS/ALAT

https://doi.org/10.1164/rccm.202202-0399ST

Role of MDT in diagnosis of IPF

https://doi.org/10.1513/AnnalsATS.202108-979ED

Current and future treatments in IPF

https://doi.org/10.1007/s40265-023-01950-0

]]> 1883 Inspire: Dr Nazia Chaudhuri Interview This week we welcome Dr Nazia Chaudhuri to the podcast. In this Inspire episode, Dr Chaudhuri tells us how respiratory chose her and gives some insights into combining clinical and academic roles. We discuss emerging research opportunities in Northern Ireland in particular in interstitial lung disease. Show Notes https://medicine.yale.edu/profile/naftali-kaminski/ Tue, 18 Mar 2025 10:51:00 -0000 full The Podcast Studios This week we welcome Dr Nazia Chaudhuri to the podcast. In this Inspire episode, Dr Chaudhuri tells us how respiratory chose her and gives some insights into combining clinical and academic roles. We discuss emerging research opportunities in Northern Ireland in particular in interstitial lung disease. Show Notes https://medicine.yale.edu/profile/naftali-kaminski/ This week we welcome Dr Nazia Chaudhuri to the podcast. In this Inspire episode,

Dr Chaudhuri tells us how respiratory chose her and gives some insights into

combining clinical and academic roles. We discuss emerging research opportunities

in Northern Ireland in particular in interstitial lung disease.



Show Notes

https://medicine.yale.edu/profile/naftali-kaminski/

]]> 1715 Breathwork: Introduction to Chronic Obstructive Pulmonary Disease (Part 2) In this episode, we speak with Dr. Breda Cushen about Chronic Obstructive Pulmonary Disease (COPD). We discuss tertiary care referrals for severe COPD, managing comorbidities, initiating treatment, and ensuring adherence. Packed with practical insights, this episode offers valuable tips to enhance COPD care across the community, outpatient clinics, and hospital settings. Chapters 01.02 Rapid Fire Round 01.50 Definition of COPD 03.10 Tertiary care referrals for severe COPD 05.01 Information to include in the referral 06.40 Work up in severe COPD clinic 08.55 Comorbidities in COPD 10.18 Treatable Traits 14.16 Asthma & COPD 17.32 Initiating treatment in COPD 21.04 Treatment of emphysema with preserved lung function 23.21 Adherence and barriers to treatment 26.17 Identifying those at risk of exacerbation 27.34 Breakthrough in COPD 29.24 Take home message Show Notes 2025 Global Initiative for Chronic Obstructive Lung Disease (GOLD) Report https://goldcopd.org/2025-gold-report/ Westerik JA, Metting EI, van Boven JF, Tiersma W, Kocks JW, Schermer TR. Associations between chronic comorbidity and exacerbation risk in primary care patients with COPD. Respir Res. 2017 Feb 6;18(1):31. doi: 10.1186/s12931-017- 0512-2. PMID: 28166777; PMCID: PMC5294875. COPD/Integrated HST Respiratory Medicine Study Day 28 th February www.rcpi.ie Mon, 24 Feb 2025 11:12:00 -0000 Breathwork: Introduction to Chronic Obstructive Pulmonary Disease (Part 2) full The Podcast Studios In this episode, we speak with Dr. Breda Cushen about Chronic Obstructive Pulmonary Disease (COPD). In this episode, we speak with Dr. Breda Cushen about Chronic Obstructive Pulmonary Disease (COPD). We discuss tertiary care referrals for severe COPD, managing comorbidities, initiating treatment, and ensuring adherence. Packed with practical insights, this episode offers valuable tips to enhance COPD care across the community, outpatient clinics, and hospital settings. Chapters 01.02 Rapid Fire Round 01.50 Definition of COPD 03.10 Tertiary care referrals for severe COPD 05.01 Information to include in the referral 06.40 Work up in severe COPD clinic 08.55 Comorbidities in COPD 10.18 Treatable Traits 14.16 Asthma & COPD 17.32 Initiating treatment in COPD 21.04 Treatment of emphysema with preserved lung function 23.21 Adherence and barriers to treatment 26.17 Identifying those at risk of exacerbation 27.34 Breakthrough in COPD 29.24 Take home message Show Notes 2025 Global Initiative for Chronic Obstructive Lung Disease (GOLD) Report https://goldcopd.org/2025-gold-report/ Westerik JA, Metting EI, van Boven JF, Tiersma W, Kocks JW, Schermer TR. Associations between chronic comorbidity and exacerbation risk in primary care patients with COPD. Respir Res. 2017 Feb 6;18(1):31. doi: 10.1186/s12931-017- 0512-2. PMID: 28166777; PMCID: PMC5294875. COPD/Integrated HST Respiratory Medicine Study Day 28 th February www.rcpi.ie In this episode, we speak with Dr. Breda Cushen about Chronic Obstructive

Pulmonary Disease (COPD). We discuss tertiary care referrals for severe COPD,

managing comorbidities, initiating treatment, and ensuring adherence. Packed with

practical insights, this episode offers valuable tips to enhance COPD care across the

community, outpatient clinics, and hospital settings.


Chapters


01.02 Rapid Fire Round

01.50 Definition of COPD

03.10 Tertiary care referrals for severe COPD

05.01 Information to include in the referral

06.40 Work up in severe COPD clinic

08.55 Comorbidities in COPD

10.18 Treatable Traits

14.16 Asthma & COPD

17.32 Initiating treatment in COPD

21.04 Treatment of emphysema with preserved lung function

23.21 Adherence and barriers to treatment

26.17 Identifying those at risk of exacerbation

27.34 Breakthrough in COPD

29.24 Take home message


Show Notes


2025 Global Initiative for Chronic Obstructive Lung Disease (GOLD) Report

https://goldcopd.org/2025-gold-report/


Westerik JA, Metting EI, van Boven JF, Tiersma W, Kocks JW, Schermer TR.

Associations between chronic comorbidity and exacerbation risk in primary care

patients with COPD. Respir Res. 2017 Feb 6;18(1):31. doi: 10.1186/s12931-017-

0512-2. PMID: 28166777; PMCID: PMC5294875.


COPD/Integrated HST Respiratory Medicine Study Day 28 th February www.rcpi.ie

]]> 1828 Inspire: Dr Breda Cushen on setting up a new service (Part 1) In this episode we speak to Dr Breda Cushen, Consultant Respiratory Physician in Beaumont hospital. Breda came back to Ireland less than 5 years ago after working as a consultant in the NHS. We discuss some of what Breda has achieved in these first few years, from virtual ward proof of concept projects to the minutiae of starting a severe COPD clinic. But also how she juggles it all and tips for others. Chapters 0.55min Intro to Dr Breda Cushen 1.40min ITS annual scientific meeting 2024 take-home messages 3.48min Career starting out 6.44min Developing a severe COPD clinic 12.05min Behind the scenes preparation 15.45min Other services built around the severe COPD clinic 17.59min Advice for others starting a service 19.55min Virtual wards proof of concept project 25.28min Juggling it all Show notes Virtual wards HSE https://www.hse.ie/eng/about/who/strategic-programmes-office- overview/national-virtual-ward-programme/ Access recordings and abstracts from previous ITS meetings https://irishthoracicsociety.com/about-us/its-scientific-meeting/ National Clinical Programme (NCP) Respiratory https://www.hse.ie/eng/about/who/cspd/ncps/ncpr/ Mon, 10 Feb 2025 02:00:00 -0000 Inspire: Dr Breda Cushen on setting up a new service (Part 1) full The Podcast Studios In this episode we speak to Dr Breda Cushen, Consultant Respiratory Physician in Beaumont hospital. Breda came back to Ireland less than 5 years ago after working as a consultant in the NHS. We discuss some of what Breda has achieved in these first few years, from virtual ward proof of concept projects to the minutiae of starting a severe COPD clinic. But also how she juggles it all and tips for others. Chapters 0.55min Intro to Dr Breda Cushen 1.40min ITS annual scientific meeting 2024 take-home messages 3.48min Career starting out 6.44min Developing a severe COPD clinic 12.05min Behind the scenes preparation 15.45min Other services built around the severe COPD clinic 17.59min Advice for others starting a service 19.55min Virtual wards proof of concept project 25.28min Juggling it all Show notes Virtual wards HSE https://www.hse.ie/eng/about/who/strategic-programmes-office- overview/national-virtual-ward-programme/ Access recordings and abstracts from previous ITS meetings https://irishthoracicsociety.com/about-us/its-scientific-meeting/ National Clinical Programme (NCP) Respiratory https://www.hse.ie/eng/about/who/cspd/ncps/ncpr/ In this episode we speak to Dr Breda Cushen, Consultant Respiratory Physician in

Beaumont hospital. Breda came back to Ireland less than 5 years ago after working as a

consultant in the NHS. We discuss some of what Breda has achieved in these first few

years, from virtual ward proof of concept projects to the minutiae of starting a severe COPD

clinic. But also how she juggles it all and tips for others.


Chapters

0.55min Intro to Dr Breda Cushen

1.40min ITS annual scientific meeting 2024 take-home messages

3.48min Career starting out

6.44min Developing a severe COPD clinic

12.05min Behind the scenes preparation

15.45min Other services built around the severe COPD clinic

17.59min Advice for others starting a service

19.55min Virtual wards proof of concept project

25.28min Juggling it all


Show notes

Virtual wards HSE https://www.hse.ie/eng/about/who/strategic-programmes-office-

overview/national-virtual-ward-programme/


Access recordings and abstracts from previous ITS meetings https://irishthoracicsociety.com/about-us/its-scientific-meeting/


National Clinical Programme (NCP) Respiratory https://www.hse.ie/eng/about/who/cspd/ncps/ncpr/

]]> 1863 Breathwork: Update on diagnosis and management of Pneumothorax 2025 (Part 2) This week we speak again to Dr Deirdre Fitzgerald on pneumothorax. We cover it all; the typical presentation, the diagnosis, categories of pneumothorax and management updates in the last 12 months. We discuss trends in the field of pleural disease and what to expect with respect to changes in guidelines in the coming years. Chapters 00.45 Introduction 01.00 Rapid fire round 01.50 Diagnosis of pneumothorax 02.30 Tests to do at presentation/ prior to referral 05.25 Initial management; does the size of the pneumothorax matter? 08.00 Conservative management of pneumothorax; the evidence 09.00 Medical management of pneumothorax 12.18 Chest drain specifics 15.28 Suction; the evidence 17.03 Removing the chest drain 17.38 Surgical management 19.08 Post pneumothorax guidance 21.23 Pitfalls in management of pneumothorax 22.28 Recent breakthroughs in pneumothorax management Show notes ERS 2024 guidelines on spontaneous pneumothorax https://publications.ersnet.org/content/erj/63/5/2300797 High flow oxygen papers https://www.bmj.com/content/4/5779/86, https://karger.com/res/article-abstract/44/2/147/286426/Noninvasive-Treatment-of Pneumothorax-with-Oxygen?redirectedFrom=fulltext BTS pleural guidelines 2023 https://thorax.bmj.com/content/78/11/1143 Mon, 27 Jan 2025 11:16:00 -0000 Breathwork: Update on diagnosis and management of Pneumothorax 2025 (Part 2) full The Podcast Studios This week we speak again to Dr Deirdre Fitzgerald on pneumothorax. We cover it all; the typical presentation, the diagnosis, categories of pneumothorax and management updates in the last 12 months. We discuss trends in the field of pleural disease and what to expect with respect to changes in guidelines in the coming years. Chapters 00.45 Introduction 01.00 Rapid fire round 01.50 Diagnosis of pneumothorax 02.30 Tests to do at presentation/ prior to referral 05.25 Initial management; does the size of the pneumothorax matter? 08.00 Conservative management of pneumothorax; the evidence 09.00 Medical management of pneumothorax 12.18 Chest drain specifics 15.28 Suction; the evidence 17.03 Removing the chest drain 17.38 Surgical management 19.08 Post pneumothorax guidance 21.23 Pitfalls in management of pneumothorax 22.28 Recent breakthroughs in pneumothorax management Show notes ERS 2024 guidelines on spontaneous pneumothorax https://publications.ersnet.org/content/erj/63/5/2300797 High flow oxygen papers https://www.bmj.com/content/4/5779/86, https://karger.com/res/article-abstract/44/2/147/286426/Noninvasive-Treatment-of Pneumothorax-with-Oxygen?redirectedFrom=fulltext BTS pleural guidelines 2023 https://thorax.bmj.com/content/78/11/1143 This week we speak again to Dr Deirdre Fitzgerald on pneumothorax. We cover it all; the typical presentation, the diagnosis, categories of pneumothorax and management updates in the last 12 months. We discuss trends in the field of pleural disease and what to expect with respect to

changes in guidelines in the coming years.


Chapters

00.45 Introduction

01.00 Rapid fire round

01.50 Diagnosis of pneumothorax

02.30 Tests to do at presentation/ prior to referral

05.25 Initial management; does the size of the pneumothorax matter?

08.00 Conservative management of pneumothorax; the evidence

09.00 Medical management of pneumothorax

12.18 Chest drain specifics

15.28 Suction; the evidence

17.03 Removing the chest drain

17.38 Surgical management

19.08 Post pneumothorax guidance

21.23 Pitfalls in management of pneumothorax

22.28 Recent breakthroughs in pneumothorax management


Show notes


ERS 2024 guidelines on spontaneous pneumothorax https://publications.ersnet.org/content/erj/63/5/2300797


High flow oxygen papers https://www.bmj.com/content/4/5779/86,


https://karger.com/res/article-abstract/44/2/147/286426/Noninvasive-Treatment-of Pneumothorax-with-Oxygen?redirectedFrom=fulltext


BTS pleural guidelines 2023 https://thorax.bmj.com/content/78/11/1143

]]> 1471 Inspire: Dr Deirdre Fitzgerald with the insight scoop into the new HSE Integrated Care Model (Part 1) Description In our first episode of 2025 we speak to Dr Deirdre Fitzgerald, Consultant Respiratory Physician in Tallaght University Hospital. Deirdre splits her time between a tertiary hospital and community integrated care hub. In this episode she talks us through the integrated care model, setting up a pleural and new innovations she has brought into all aspects of her practice. Chapters 00.42 Introduction to Dr Deirdre Fitzgerald 01.33 Career path in Ireland 03.30 Fellowship in Perth, Australia 08.30 New consultant life 12.12 Management skills 15.20 Setting up a service 17.15 The community integrated care program 21.45 HSE Community hubs 22.10 Innovation in healthcare 24.48 Top tips for trainees Show notes Integrated care overview: https://www.hse.ie/eng/about/who/cspd/icp/ A guide for referral to Integrated care specialist services: https://www.hse.ie/eng/about/who/cspd/icp/chronic-disease/a-guide-for-referral-of-patients-to-the-chronic-disease-ambulatory-care-hub-services.pdf Innovations: https://www.hse.ie/eng/about/our-health-service/making-it- better/deirdre-seeks-to-improve-patient-care-through-innovation-at-tallaght-hospital.html Handheld ultrasound devices: https://www.butterflynetwork.com/?srsltid=AfmBOorQlIy9yP57vpTcQsFn7745-VmB6MwFdTvTd0WGSXMigfj32SvQ Lumen: https://lumen5.com/user/marissaocallaghan/untitled-video-qees0/ Mon, 13 Jan 2025 04:30:00 -0000 Inspire: Dr Deirdre Fitzgerald with the insight scoop into the new HSE Integrated Care Model (Part 1) full The Podcast Studios In our first episode of 2025 we speak to Dr Deirdre Fitzgerald, Consultant Respiratory Physician in Tallaght University Hospital Description In our first episode of 2025 we speak to Dr Deirdre Fitzgerald, Consultant Respiratory Physician in Tallaght University Hospital. Deirdre splits her time between a tertiary hospital and community integrated care hub. In this episode she talks us through the integrated care model, setting up a pleural and new innovations she has brought into all aspects of her practice. Chapters 00.42 Introduction to Dr Deirdre Fitzgerald 01.33 Career path in Ireland 03.30 Fellowship in Perth, Australia 08.30 New consultant life 12.12 Management skills 15.20 Setting up a service 17.15 The community integrated care program 21.45 HSE Community hubs 22.10 Innovation in healthcare 24.48 Top tips for trainees Show notes Integrated care overview: https://www.hse.ie/eng/about/who/cspd/icp/ A guide for referral to Integrated care specialist services: https://www.hse.ie/eng/about/who/cspd/icp/chronic-disease/a-guide-for-referral-of-patients-to-the-chronic-disease-ambulatory-care-hub-services.pdf Innovations: https://www.hse.ie/eng/about/our-health-service/making-it- better/deirdre-seeks-to-improve-patient-care-through-innovation-at-tallaght-hospital.html Handheld ultrasound devices: https://www.butterflynetwork.com/?srsltid=AfmBOorQlIy9yP57vpTcQsFn7745-VmB6MwFdTvTd0WGSXMigfj32SvQ Lumen: https://lumen5.com/user/marissaocallaghan/untitled-video-qees0/ Description

In our first episode of 2025 we speak to Dr Deirdre Fitzgerald, Consultant Respiratory Physician in Tallaght University Hospital. Deirdre splits her time between a tertiary hospital and community integrated care hub. In this episode she talks us through the integrated care model, setting up a pleural and new innovations she has brought into all aspects of her practice.


Chapters

00.42 Introduction to Dr Deirdre Fitzgerald

01.33 Career path in Ireland

03.30 Fellowship in Perth, Australia

08.30 New consultant life

12.12 Management skills

15.20 Setting up a service

17.15 The community integrated care program

21.45 HSE Community hubs

22.10 Innovation in healthcare

24.48 Top tips for trainees


Show notes





]]> 1657 Breathwork: Obstructive Sleep Apnoea demystified (Part 2) Dr Brian Kent covers the key information to be included in your sleep apnoea referrals and also key components of investigation and management of obstructive sleep apnoea. He also describes the advances in technology, wearables and medical treatment coming down the line. Tirzepatide in OSA NEJM paper: https://www.nejm.org/doi/10.1056/NEJMoa2404881 CPAP in OSA: https://www.nejm.org/doi/full/10.1056/NEJMoa1606599 https://thorax.bmj.com/content/61/5/430.long Con/pro debate for asymptomatic patients with OSA Pro: https://pmc.ncbi.nlm.nih.gov/articles/PMC6395978/ Con: https://publications.ersnet.org/content/breathe/15/1/11 Non-CPAP therapies in OSA: https://publications.ersnet.org/content/errev/30/162/210200 Lumen post: https://lumen5.com/user/marissaocallaghan/bk-breath-work-trail-fiig4/ Mon, 30 Dec 2024 03:00:00 -0000 Breathwork: Obstructive Sleep Apnoea demystified (Part 2) full The Podcast Studios Dr Brian Kent covers the key information to be included in your sleep apnoea referrals and also key components of investigation and management of obstructive sleep apnoea. He also describes the advances in technology, wearables and medical treatment coming down the line. Tirzepatide in OSA NEJM paper: https://www.nejm.org/doi/10.1056/NEJMoa2404881 CPAP in OSA: https://www.nejm.org/doi/full/10.1056/NEJMoa1606599 https://thorax.bmj.com/content/61/5/430.long Con/pro debate for asymptomatic patients with OSA Pro: https://pmc.ncbi.nlm.nih.gov/articles/PMC6395978/ Con: https://publications.ersnet.org/content/breathe/15/1/11 Non-CPAP therapies in OSA: https://publications.ersnet.org/content/errev/30/162/210200 Lumen post: https://lumen5.com/user/marissaocallaghan/bk-breath-work-trail-fiig4/ Dr Brian Kent covers the key information to be included in your sleep apnoea referrals and also key components of investigation and management of obstructive sleep apnoea. He also describes the advances in technology, wearables and medical treatment coming down the line.


Tirzepatide in OSA NEJM paper: https://www.nejm.org/doi/10.1056/NEJMoa2404881

CPAP in OSA: https://www.nejm.org/doi/full/10.1056/NEJMoa1606599

https://thorax.bmj.com/content/61/5/430.long

Con/pro debate for asymptomatic patients with OSA

Pro: https://pmc.ncbi.nlm.nih.gov/articles/PMC6395978/

Con: https://publications.ersnet.org/content/breathe/15/1/11

Non-CPAP therapies in OSA: https://publications.ersnet.org/content/errev/30/162/210200


Lumen post: https://lumen5.com/user/marissaocallaghan/bk-breath-work-trail-fiig4/

]]> 1722 Inspire: Your cue to get involved in European societies with Dr Brian Kent (Part 1) This week, we speak with Dr Brian Kent, Consultant Respiratory physician in St James's Hospital, Dublin. Brian shares his experience as chief editor of Breathe, the clinical educational journal of the European Respiratory Society with insider tips and advice on how to successfully submit to a journal. ERS Breathe: https://publications.ersnet.org/content/breathe Breathe instructions for authors: https://publications.ersnet.org/authors/breathe/instructions A gin guide. Avoid a faux pas: https://www.theginguide.com/ Lumen post: https://lumen5.com/user/marissaocallaghan/bk-inspire-trailer-cxi4m/ Mon, 16 Dec 2024 04:00:00 -0000 Inspire: Your cue to get involved in European societies with Dr Brian Kent (Part 1) full The Podcast Studios This week, we speak with Dr Brian Kent, Consultant Respiratory physician in St James's Hospital, Dublin. Brian shares his experience as chief editor of Breathe, the clinical educational journal of the European Respiratory Society with insider tips and advice on how to successfully submit to a journal. ERS Breathe: https://publications.ersnet.org/content/breathe Breathe instructions for authors: https://publications.ersnet.org/authors/breathe/instructions A gin guide. Avoid a faux pas: https://www.theginguide.com/ Lumen post: https://lumen5.com/user/marissaocallaghan/bk-inspire-trailer-cxi4m/ This week, we speak with Dr Brian Kent, Consultant Respiratory physician in St James's Hospital, Dublin. Brian shares his experience as chief editor of Breathe, the clinical educational journal of the European Respiratory Society with insider tips and advice on how to successfully submit to a journal.


ERS Breathe: https://publications.ersnet.org/content/breathe

Breathe instructions for authors: https://publications.ersnet.org/authors/breathe/instructions

A gin guide. Avoid a faux pas: https://www.theginguide.com/


Lumen post: https://lumen5.com/user/marissaocallaghan/bk-inspire-trailer-cxi4m/

]]> 1741 Breathwork: Airway Clearance with Aoife Sheehan This episode we interview Aoife Sheehan, critical care physiotherapist. She gives a clinical update on airway clearance. Mon, 25 Nov 2024 04:00:00 -0000 Breathwork: Airway Clearance with Aoife Sheehan full The Podcast Studios This episode we interview Aoife Sheehan, critical care physiotherapist. She gives a clinical update on airway clearance. This episode we interview Aoife Sheehan, critical care physiotherapist. She gives a clinical update on airway clearance.

]]> 1650 Inspire - interview with Aoife Sheehan, career insights into respiratory physiotherapy This episode we speak with Aoife Sheehan, critical care and respiratory physiotherapist about the career progression of a physiotherapist, the diversity of the profession and exciting advances, as well as the beneficial role of committees and societies and more.    Podcast Update:  Tune in this week to hear Aoife Sheehan, critical care physiotherapist on all things respiratory physiotherapy, including the diversity of the role and how there is no average day.  https://lumen5.com/user/edofficer/the-dynamics-of-crit-wbnak/ Mon, 11 Nov 2024 05:00:00 -0000 Inspire - interview with Aoife Sheehan, career insights into respiratory physiotherapy full The Podcast Studios This episode we speak with Aoife Sheehan, critical care and respiratory physiotherapist about the career progression of a physiotherapist, the diversity of the profession and exciting advances, as well as the beneficial role of committees and societies and more.    Podcast Update:  Tune in this week to hear Aoife Sheehan, critical care physiotherapist on all things respiratory physiotherapy, including the diversity of the role and how there is no average day.  https://lumen5.com/user/edofficer/the-dynamics-of-crit-wbnak/ This episode we speak with Aoife Sheehan, critical care and respiratory physiotherapist about the career progression of a physiotherapist, the diversity of the profession and exciting advances, as well as the beneficial role of committees and societies and more. 

 

Podcast Update: 

Tune in this week to hear Aoife Sheehan, critical care physiotherapist on all things respiratory physiotherapy, including the diversity of the role and how there is no average day. 

https://lumen5.com/user/edofficer/the-dynamics-of-crit-wbnak/

]]> 1247 Breathwork; Malignant Airway Obstruction with Dr Marcus Kennedy This week we speak with Dr Marcus Kennedy about malignant central airway obstruction, an underreported and daunting complication of lung cancer. We cover presentation, diagnosis and current management of malignant airway obstruction and also discuss novel therapies in the field.  Central airway obstruction Ernst et al ARJCCM 2004 https://www.atsjournals.org/doi/epdf/10.1164/rccm.200210-1181SO?role=tab Malignant central airway obstruction Mudambi et al 2017 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696549/pdf/jtd-09-S10-S1087.pdf Irish NCCP lung cancer website for healthcare professionals https://www.hse.ie/eng/services/list/5/cancer/profinfo/guidelines/lung-cancer/ Social Media: https://lumen5.com/user/edofficer/lung-cancer-treatmen-888tv/  Mon, 28 Oct 2024 00:00:00 -0000 Breathwork; Malignant Airway Obstruction with Dr Marcus Kennedy full The Podcast Studios This week we speak with Dr Marcus Kennedy about malignant central airway obstruction, an underreported and daunting complication of lung cancer. We cover presentation, diagnosis and current management of malignant airway obstruction and also discuss novel therapies in the field.  Central airway obstruction Ernst et al ARJCCM 2004 https://www.atsjournals.org/doi/epdf/10.1164/rccm.200210-1181SO?role=tab Malignant central airway obstruction Mudambi et al 2017 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696549/pdf/jtd-09-S10-S1087.pdf Irish NCCP lung cancer website for healthcare professionals https://www.hse.ie/eng/services/list/5/cancer/profinfo/guidelines/lung-cancer/ Social Media: https://lumen5.com/user/edofficer/lung-cancer-treatmen-888tv/  This week we speak with Dr Marcus Kennedy about malignant central airway obstruction, an underreported and daunting complication of lung cancer. We cover presentation, diagnosis and current management of malignant airway obstruction and also discuss novel therapies in the field. 



]]> 1568 Inspire - Interview with Dr Marcus Kennedy; ITS presidency, The farmers journal and how he ended up in Cork This week, we speak with Dr Marcus Kennedy, Consultant Respiratory physician in Cork University Hospital. Marcus speaks about his respiratory medicine training, his experience and ambitions as president of the Irish thoracic society. TS website https://irishthoracicsociety.com/    ERS website https://www.ersnet.org,  World Bronchoscopy society https://www.wabip.com Farmers Journal article https://www.farmersjournal.ie/life/health/asbestos-for-farmers-the-risk-is-in-old-machinery-and-older-buildings-793329 Social Media: https://lumen5.com/user/edofficer/clean-air-initiative-il2av/ and/or https://lumen5.com/user/edofficer/asbestos-awareness-i-to99s/ Thu, 17 Oct 2024 15:24:17 -0000 Inspire - Interview with Dr Marcus Kennedy; ITS presidency, The farmers journal and how he ended up in Cork full The Podcast Studios This week, we speak with Dr Marcus Kennedy, Consultant Respiratory physician in Cork University Hospital. Marcus speaks about his respiratory medicine training, his experience and ambitions as president of the Irish thoracic society. TS website https://irishthoracicsociety.com/    ERS website https://www.ersnet.org,  World Bronchoscopy society https://www.wabip.com Farmers Journal article https://www.farmersjournal.ie/life/health/asbestos-for-farmers-the-risk-is-in-old-machinery-and-older-buildings-793329 Social Media: https://lumen5.com/user/edofficer/clean-air-initiative-il2av/ and/or https://lumen5.com/user/edofficer/asbestos-awareness-i-to99s/ This week, we speak with Dr Marcus Kennedy, Consultant Respiratory physician in Cork University Hospital. Marcus speaks about his respiratory medicine training, his experience and ambitions as president of the Irish thoracic society.


]]> 1335 Breathwork; Lymphangioleiomyomatosis with Dr Evelyn Lynn Today's guest is Dr Evelyn Lynn, a pulmonology fellow/ respiratory SpR and a graduate of the royal college of surgeons, Dublin. She is currently in her final year of fellowship. We speak to Evelyn about choosing and interviewing for respiratory fellowship and her training to date. - Update prevalence of LAM Europe Lynn et al ARJCCM 2024 https://doi.org/10.1164/rccm.202310-1736LE   - LAM flash card Mon, 30 Sep 2024 03:00:00 -0000 Breathwork; Lymphangioleiomyomatosis with Dr Evelyn Lynn full The Podcast Studios Today's guest is Dr Evelyn Lynn, a pulmonology fellow/ respiratory SpR and a graduate of the royal college of surgeons, Dublin. She is currently in her final year of fellowship. We speak to Evelyn about choosing and interviewing for respiratory fellowship and her training to date. - Update prevalence of LAM Europe Lynn et al ARJCCM 2024 https://doi.org/10.1164/rccm.202310-1736LE   - LAM flash card Today's guest is Dr Evelyn Lynn, a pulmonology fellow/ respiratory SpR and a graduate of the royal college of surgeons, Dublin. She is currently in her final year of fellowship. We speak to Evelyn about choosing and interviewing for respiratory fellowship and her training to date.


- Update prevalence of LAM Europe Lynn et al ARJCCM 2024 https://doi.org/10.1164/rccm.202310-1736LE  

- LAM flash card

]]> 1449 Inspire - Interview with Dr. Evelyn Lynn (Part 1) Today's guest is Dr Evelyn Lynn, a pulmonology fellow/ respiratory SpR and a graduate of the royal college of surgeons, Dublin. She is currently in her final year of fellowship. We speak to Evelyn about choosing and interviewing for respiratory fellowship and her training to date. - Update prevalence of LAM Europe Lynn et al ARJCCM 2024 https://doi.org/10.1164/rccm.202310-1736LE   - LAM flash card Thu, 19 Sep 2024 08:32:00 -0000 Inspire - Interview with Dr. Evelyn Lynn (Part 1) full The Podcast Studios Today's guest is Dr Evelyn Lynn, a pulmonology fellow/ respiratory SpR and a graduate of the royal college of surgeons, Dublin. She is currently in her final year of fellowship. We speak to Evelyn about choosing and interviewing for respiratory fellowship and her training to date. - Update prevalence of LAM Europe Lynn et al ARJCCM 2024 https://doi.org/10.1164/rccm.202310-1736LE   - LAM flash card Today's guest is Dr Evelyn Lynn, a pulmonology fellow/ respiratory SpR and a graduate of the royal college of surgeons, Dublin. She is currently in her final year of fellowship. We speak to Evelyn about choosing and interviewing for respiratory fellowship and her training to date.


- Update prevalence of LAM Europe Lynn et al ARJCCM 2024 https://doi.org/10.1164/rccm.202310-1736LE  

- LAM flash card

]]> 1904 Breathwork; Introduction to Asthma with Dr Marcus Butler Social Media Website: https://irishthoracicsociety.com/ X/Twitter: irishthoracicS LinkedIn: Irish Thoracic Society  Instagram: Irishthoracicsociety Mon, 02 Sep 2024 09:00:00 -0000 Breathwork; Introduction to Asthma with Dr Marcus Butler full The Podcast Studios Social Media Website: https://irishthoracicsociety.com/ X/Twitter: irishthoracicS LinkedIn: Irish Thoracic Society  Instagram: Irishthoracicsociety Social Media

Website: https://irishthoracicsociety.com/

X/Twitter: irishthoracicS

LinkedIn: Irish Thoracic Society 

Instagram: Irishthoracicsociety

]]> 1655 Breathwork - Trailer Struggling to keep up with respiratory medicine? We get it. That's why we created Breathwork, the podcast. Each month, we chat with world-leading respiratory experts and break down everything you need to know. Whether you're commuting, running, walking, or taking a lunch break, Breathwork keeps you up to date with the latest in respiratory medicine through engaging conversations with top specialists. Tune in and stay informed! Social Media Website: https://irishthoracicsociety.com/ X/Twitter: irishthoracicS LinkedIn: Irish Thoracic Society  Instagram: Irishthoracicsociety Mon, 26 Aug 2024 10:21:00 -0000 Breathwork - Trailer trailer The Podcast Studios Struggling to keep up with respiratory medicine? We get it. That's why we created Breathwork, the podcast. Each month, we chat with world-leading respiratory experts and break down everything you need to know. Whether you're commuting, running, walking, or taking a lunch break, Breathwork keeps you up to date with the latest in respiratory medicine through engaging conversations with top specialists. Tune in and stay informed! Social Media Website: https://irishthoracicsociety.com/ X/Twitter: irishthoracicS LinkedIn: Irish Thoracic Society  Instagram: Irishthoracicsociety Struggling to keep up with respiratory medicine? We get it. That's why we created Breathwork, the podcast. Each month, we chat with world-leading respiratory experts and break down everything you need to know. Whether you're commuting, running, walking, or taking a lunch break, Breathwork keeps you up to date with the latest in respiratory medicine through engaging conversations with top specialists. Tune in and stay informed!


Social Media

Website: https://irishthoracicsociety.com/

X/Twitter: irishthoracicS

LinkedIn: Irish Thoracic Society 

Instagram: Irishthoracicsociety

]]> 31 Inspire - Interview with Dr. Marcus Butler (Part 1) Welcome to the first episode of the Irish Thoracic Society Inspire Podcast! Today's guest is Dr. Marcus Butler, a graduate of NUI Galway who earned his MD from the Royal College of Surgeons in Ireland. He completed fellowship training at New York-Presbyterian/Weill Cornell and later joined their faculty as an attending physician in pulmonary and critical care. Social Media Website: https://irishthoracicsociety.com/ X/Twitter: irishthoracicS LinkedIn: Irish Thoracic Society  Instagram: Irishthoracicsociety Mon, 19 Aug 2024 03:00:00 -0000 Inspire - Interview with Dr. Marcus Butler (Part 1) full 1 The Podcast Studios Welcome to the first episode of the Irish Thoracic Society Inspire Podcast! Today's guest is Dr. Marcus Butler, a graduate of NUI Galway who earned his MD from the Royal College of Surgeons in Ireland. He completed fellowship training at New York-Presbyterian/Weill Cornell and later joined their faculty as an attending physician in pulmonary and critical care. Social Media Website: https://irishthoracicsociety.com/ X/Twitter: irishthoracicS LinkedIn: Irish Thoracic Society  Instagram: Irishthoracicsociety Welcome to the first episode of the Irish Thoracic Society Inspire Podcast!

Today's guest is Dr. Marcus Butler, a graduate of NUI Galway who earned his MD from the Royal College of Surgeons in Ireland. He completed fellowship training at New York-Presbyterian/Weill Cornell and later joined their faculty as an attending physician in pulmonary and critical care.


Social Media

Website: https://irishthoracicsociety.com/

X/Twitter: irishthoracicS

LinkedIn: Irish Thoracic Society 

Instagram: Irishthoracicsociety

]]> 1402 Inspire - Trailer https://irishthoracicsociety.com/ In the dark about what lies ahead of you in your career in respiratory medicine? Us too, or at least some of it! This is why we speak to experts in the field every month with the sole purpose of demystifying the next step or level. Tune into the Inspire podcast and learn about your current future or even past respiratory medicine colleagues. See what they have to say about their career to date, future plans and advice for others hoping to pursue or currently on a similar journey you. -- Website: https://irishthoracicsociety.com/ X/Twitter: irishthoracicS LinkedIn: Irish Thoracic Society  Instagram: Irishthoracicsociety Thu, 15 Aug 2024 15:16:35 -0000 Inspire - Trailer trailer The Podcast Studios In the dark about what lies ahead of you in your career in respiratory medicine? Us too, or at least some of it! This is why we speak to experts in the field every month with the sole purpose of demystifying the next step or level. Tune into the Inspire podcast and learn about your current future or even past respiratory medicine colleagues. See what they have to say about their career to date, future plans and advice for others hoping to pursue or currently on a similar journey you. -- Website: https://irishthoracicsociety.com/ X/Twitter: irishthoracicS LinkedIn: Irish Thoracic Society  Instagram: Irishthoracicsociety In the dark about what lies ahead of you in your career in respiratory medicine? Us too, or at least some of it!

This is why we speak to experts in the field every month with the sole purpose of demystifying the next step or level. Tune into the Inspire podcast and learn about your current future or even past respiratory medicine colleagues.

See what they have to say about their career to date, future plans and advice for others hoping to pursue or currently on a similar journey you.

--

Website: https://irishthoracicsociety.com/

X/Twitter: irishthoracicS

LinkedIn: Irish Thoracic Society 

Instagram: Irishthoracicsociety

]]> 27 no